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ABSTRACT 
 
RHODIUM-CATALYZED REACTIONS OF (Z)-2-EN-4- 
YNE ACETATES WITH ARYLBORONIC ACIDS 
 
This study is the first example of rhodium(I)-catalyzed arylative SN2” type 
reaction of (Z)-2-en-4-yne acetates with arylboronic acids leading to E-configured 
vinyl-allenes with an aryl moiety.  
The coordinative interaction of the rhodium with carbonyl oxygen promoted 
the -elimination of Rh(I)-OAc from the alkenylrhodium intermediate in both syn- and 
anti-modes, with the syn-elimination being the major path. DFT calculations revealed 
that a conformer of this intermediate which can lead to the E-configured vinylallene 
product via the syn-elimination mode, is energetically the most favorable conformer. 
The rhodium-catalyzed procedure is not applicable to reactions involving (E)-
configured enyne acetates, because the geometry of the alkenylrhodium intermediate 
that is derived from the corresponding E-enyne acetate would not allow such 
coordinative interaction to occur. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 v 
ÖZET 
 
(Z)-2-EN-4-N ASETATLARIN ARLBORONK  
ASTLERLE RODYUM-KATALZL TEPKMELER 
 
Bu çalıma (Z)-2-en-4yne asetatların arilboronik asitler ile rodyum(I) katalizli 
arilatif SN2” tipi reaksiyonları sonucunda E-konfigürasyonuna sahip, aril grubu içeren 
vinil allenlerin olumasını gösteren ilk örnektir.  
Rodyumun karbonil oksijeni ile koordinatif etkileimi Rh(I)-OAc 
kompleksinin alkenilrodyum ara ürününden -ayrılma yapmasını hem syn hem de anti 
biçiminde, desteklemektedir. Ancak syn ayrılma ürünü ana üründür. DFT hesaplamaları 
syn-ayrılma yoluyla elde edilen E-konfigürasyonuna sahip vinilallenin ara ürününün 
enerji açıından en uygun konformasyon olduunu göstermitir. E-konfigürasyonuna 
sahip enin asetatların rodyum katalizli tepkimeleri uygulanabilir deildir. Bunun nedeni 
E-enin asetatın oluturduu alkenilrodyum ara ürününün geometrik yapısı karbonil 
oksijeniyle koordinatif etkileimin olumasına izin vermez.   
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CHAPTER 1 
 
INTRODUCTION 
 
Studies on transition metal catalyzed reactions have suddenly increased over 
the last two decades for the formation of C-C bonds. Rhodium-catalyzed addition 
reactions to different type of unsaturated systems are one of the examples of C-C bond 
forming process. Organometallic reagents such as Grignard, organocopper, 
organolithium, and organozinc are classical nucleophilic reagents for carbon-carbon 
coupling reactions. However, these reagents are of various restrictions in their 
utilization, because they are air and moisture sensitive, have very short shelf-live, and 
tolerates only few electrophilic groups. Thus, use of these reagents requires strict 
anhydrous conditions and inert atmosphere.  
Due to above mentioned disadvantages of organometallic reagents, 
organoboron reagents bearing aryl and alkenyl groups are preferred for the transition 
metal catalyzed C-C bond forming reactions. Organoboron reagents are highly stable to 
oxygen and moisture, easy-to-handle without special precautions, and allow application 
of a wide range of reactive functional groups.  
Organoboron  reagents readily undergo transmetalation with rhodium species 
to produce arylrhodium(I) structures that have ability to induce the nucleophilic 
arylation of electrophilic sides (Fagnou and Lautens 2003; Sakai, et al. 1997).  
There are many different methods for Rh-catalyzed reactions of organoboronic 
reagents with unsaturated systems in the literature (Fagnou and Lautens 2003; Hayashi 
and Yamasaki 2003; Miura, et al. 2007; Murakami and Igawa 2002; Nishimura, et al. 
2010; Sakai, et al. 1997; Sakuma, et al. 2000). In 1999, It was reported that (E)-2-en-4-
yne acetates react with different type of lithium cuprates leading to alkylated E- and Z- 
isomeric mixtures of vinylallenes (Purpura and Krause 1999). In 2002, Murakami and 
Igawa reported that propargyl acetates react with phenylboronic acids in the presence of 
rhodium(I) catalyst to produce allenic product with -oxygen elimination. 
Within the context of this thesis, we developed a new method for the rhodium 
catalyzed arylative reaction of (Z)-2-en-4-yne acetates with arylboronic acids to produce 
 2 
E-configured vinyl-allenes. This method offered simple and mild conditions a obtaining 
the single diastreomer of allenic products. 
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CHAPTER 2 
 
TRANSITION METAL-CATALYZED REACTIONS OF  
ORGANOBORONS 
 
2.1. Organoborons 
 
Chemical compounds bearing a functional group such as aryl or alkyl on the 
boron atoms are called organoborons. The term organoborons refers to a compound 
which has at least one C-B bond. Despite not having any C-B bonds, trialkoyxboranes 
are also categorized as organoboron. Boron atom is capable of forming stable covalent 
bond like carbon atom. Trivalent boron compounds provide electrophilic property with 
trigonal planar structure.  However, further addition of a bond to boron produces 
tetravalent boron compound having tetrahedral structure and shows nucleophilic 
property (Figure 3.1).            
Boron compounds can be used in many useful chemical reactions such as 
asymmetric synthesis, metal-catalysis, acid-catalysis, multicomponent reactions, 
biological and medical applications and in many areas from pharmaceuticals to 
materials because of electronic, structural and reactivity properties of organoborons.   
 
 
 
Figure 2.1. The structure of organoboron compounds 
             (Source: Petasis 2007) 
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2.2. Catalytic Cycle of Rh and Group 10 Metals 
 
Transition metal catalyzed reactions provide very important contribution in the 
art of chemical synthesis. Unprecedented selectivity and new types of bond 
constructions have raised metal-mediated reactions. Transition metals can catalyze 
multistep reactions and this behavior is the one of the most important asset for them. 
They show variable oxidation states with finely controlled and tunable redox potentials 
because of changing the d-orbital energies and spacing with different ligands.  
In the literature, there are many examples of transition-metal-catalyzed 
conjugate addition reactions of organoborons to the unsaturated systems.  
Palladium(0)-catalyzed conjugate addition of aromatics to ,-unsaturated 
compounds with sodium tetraphenylborate and arylboronic acids was performed in the 
presence of antimony (III) chloride (Cho, et al. 1995). In 2006, it was reported that 
conjugate addition of arylboronic acids to ,-unsaturated carbonyl compounds 
proceeded with high yields in the presence of a palladium/bipyridine catalyst in aqueous 
media (Lin and Lu 2006). 2,4-Diarylquinolines were synthesized via the Pd-catalyzed 
hydroarylation of ,ß -ynones with organoboron derivatives (Arcadi, et al. 2008). 
It was reported that palladium-catalyzed ring-opening addition of various 
arylboronic acids to heterobicyclic alkenes such as aza- and oxabicyclic alkenes resulted 
in formation of the corresponding products in excellent yields (Lautens and 
Dockendorff 2003). 
In 2003, first palladium catalyzed reaction of organoboronic acids to alkynes 
have been reported (Oh, et al. 2003).  
In 2007, it was published arylation of aromatic aldehydes with arylboroxines in 
the presence of Ni-phosphine ligand (Arao, et al. 2007). 
When general catalytic cycle for Ni, Pd and Pt are investigated, it is observed 
that catalytic cycle moves around between (0) and (II) oxidation states and 
transmetalation can only occur with the metal(II) species in the cycle (Figure 2.2). If it 
is desired to viable reactions, a suitable electrophilic component must be incorporated 
that will oxidatively add to the metal(0) complex to produce the organometal(II) 
species.  
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Figure 2.2. Possible catalytic cycle for Ni, Pd and Pt 
  (Source: Fagnou and Lautens 2003) 
  
In the past twenty years, there has been dramatic increase in the use of 
transition metal-catalyzed reactions for the organic synthesis. Recently, much attention 
is given to rhodium catalysts in constructing carbon-carbon bond, since the rhodium-
catalyzed reactions provide milder and more benign protocols. 
Rhodium demonstrates interesting and different catalytic properties when the 
catalytic cycle is compared with group 10 metals such as Ni, Pd and Pt. Rhodium 
typically moves around between the (I) and (III) oxidation states in catalytic reactions 
with organometallic reagent. Transmetalation can occur with rhodium(I) and an 
organometallic compound to generate an organorhodium(I) which is capable of reacting 
in new ways. Addition of a suitable electrophile will produce a catalytic cycle (cycle B) 
as illustrated in Figure 2.3, which involves an oxidative addition. Alternatively, the 
organorhodium complex can be couple with an unsaturated unit of an organic 
compound as illustrated in cycle C. The outcome of cycle C is a net R and, H-addition 
across the unsaturated unit. 
A wide variety of organometallic compounds reacts with rhodium(I) halides to 
generate rhodium-aryl complexes. 
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Figure 2.3. Possible catalytic cycles for Rh-catalyst 
                  (Source: Fagnou and Lautens 2003) 
 
2.2.1. Structural Properties of Aryl-Rhodium Complexes 
 
Different type of crystal structure of aryl-rhodium complexes have been 
obtained with various kinds of ligands. Steric interactions between aryl group and 
adjacent ligand can be minimized by proper orientation. Aryl ring should be orthogonal 
to the square plane of the complex (Figure 2.4). 
 
 
 
Figure 2.4. Rhodium-aryl complexes characterized crystallographically 
(Source: Fagnou and Lautens 2003) 
 
It can be seen that ortho-substituent on the arene situated below or above the 
square plane to prevent the empty coordination sites (Figure 2.5). The rate of associative 
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ligand process slows down with these complexes when bulky ortho-substituents are 
present.   
 
 
 
Figure 2.5. Effect of o-substituent 
(Source: Fagnou and Lautens 2003) 
 
2.3. Rhodium-Catalyzed Addition of Organoborons to Cyclic and 
Acyclic Enones 
 
The first study in this research area was achieved in 1997. It was reported that 
Rh(I) complexes catalyze 1,4-addition of aryl and alkenylboronic acids to conjugated 
enones in aqueous solvents to give excellent yield (Sakai, et al. 1997) (Figure 2.6). 
Different type of ligands were investigated by using [Rh(acac)(CO)2] as the rhodium(I) 
source. Bis(phosphine) ligands having large bite angles gave rise the best results. The 
presence of water also was necessary to provide a good reactivity.   
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Figure 2.6. Rh-catalyzed  reaction of boronic acids to enones 
(Source: Sakai, et al. 1997) 
 
In 1998, the reaction conditions were modified for example the reaction 
temperature was elevated from 50 oC to 100 oC, and the rhodium source was changed 
from [Rh(acac)(CO)2] to [Rh(acac)(C2H4)2] Furthermore high enantioselectivities could 
be achieved by using a chiral ligand such as (S)-BINAP (Takaya, et al. 1998) (Figure 
2.7).   
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Figure 2.7. Enantioselective Rh-catalyzed reaction of boronic acids with enones 
(Source: Takaya, et al. 1998) 
 
2.4. Rhodium-Catalyzed Reactions of Organoborons with Aldehydes 
 
It was demonstrated that the rhodium-catalyzed reaction of organoboronic 
acids with aldehydes gave secondary alcohols in good yields (Sakai, et al. 1998) (Figure 
2.8). 
 
 
 
Figure 2.8. Rh-catalyzed addition reaction of boronic acids to aldehydes 
(Source: Sakai, et al. 1998) 
 
They proposed a mechanism which involves a nucleophilic attack of the aryl 
group on the arylrhodium(I) species (Figure 2.9). 
 
 
 
Figure 2.9. The reaction mechanism of Rh-catalyzed reaction of boronic acids with 
aldehydes.  (Source: Takaya, et al. 1998) 
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Excellent catalytic activity was obtained in the addition of arylboronic acids to 
aldehydes with cationic rhodium complexes of certain nitrogen-containing ligands 
(Moreau, et al. 2001). In 2004, it was reported that the addition of arylboronic acids to 
aldehydes with novel Rh-carbene complexes led to high yields (Özdemir, et al. 2004). 
 
2.5. Rhodium-Catalyzed Reactions of Organoborons with Alkenes, 
Alkynes and Their Derivatives 
 
An interesting multiple alkylation reaction which is also called merry-go-round 
reaction was demonstrated (Oguma, et al. 2000). They synthesized a unique class of 
sterically encumbered aromatic molecules by Rh-catalyzed multistep arylation reaction 
with arylboronic acids (Figure 2.10).  
 
 
 
Figure 2.10. Rh-catalyzed multiple alkylation on aromatic ring 
( Source: Oguma, et al. 2000) 
 
The rhodium-catalyzed reaction of arylboronic acids with olefins was achieved 
by using water soluble phosphine ligand, disulfonated triphenylphosphine (TPPDS) and 
trisulfonated triphenylphosphine (TPPTS) (Lautens, et al. 2001) (Figure 2.11). 
 
 
 
Figure 2.11. Rh-catalyzed coupling reactions of alkenes with arylboronic acids 
( Source: Lautens, et al. 2001) 
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It was published in 2008 that the rhodium(I)-catalyzed reaction of 
fluoroalkylated electron deficient olefins with arylboronic acids gave rise to 1,4-
addition products in good yields and high selectivities in the presence of (S)-BINAP in 
a toluene/water solvent system (Konno, et al. 2008) (Figure 2.12).  
 
 
 
Figure 2.12. Rh-catalyzed 1,4-addition of boronic acids to the fluoroalkylated 
  electrondeficient olefins ( Source: Konno, et al. 2008) 
 
Alkynes give addition reaction with arylboronic acids similar to the alkenes. It 
was reported that the rhodium-catalyzed hydroarylation reaction of internal alkynes lead 
to trisubstituted alkenes in high yields (Hayashi, et al. 2001) (Figure 2.13).  
 
  
 
Figure 2.13. Rh catalyzed hydroarylation of alkynes ( Source: Hayashi, et al. 2001) 
 
Also, in this study it was proved that 1,4-shift of rhodium took place from 2-
aryl-1-alkenylrhodium to 2-alkenylarylrhodium intermediate in the proposed 
mechanism of the reaction (Figure 2.14).  
 
 
Figure 2.14. The proposed mechanism for Rh-catalyzed hydroarylation of alkynes 
(Source: Hayashi, et al. 2001) 
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Alkynyl heteroaromatic compounds reacted with arylboronic acids in the 
presence of rhodium catalyst to form trisubstituted alkenes as addition products in a 
high regioselectivity (Figure 2.15) (Lautens, et al. 2001). 
 
N
R
N
R
Ar
+ ArB(OH)2
2 mol % [Rh(cod)Cl]2
8 mol % ligand
SDS, Na2CO3, H2O, 80 oC
 
 
Figure 2.15. Rh catalyzed addition of arylboronic acids to pyridine substituted alkynes 
(Source: Lautens, et al. 2001) 
 
In this study, they observed that the method is applicable only to alkynes in 
which alkynyl group is attached to ortho position whereas those bearing alkynyl group 
at the meta and para positions were completely unreactive toward the rhodium-
catalyzed procedure..  
Hayashi and his coworkers reported that the rhodium-catalyzed regioselective 
coupling reaction of alkynes with orto-carbonylated arylboronic acids under mild 
conditions led to indenols in relatively high enantioselectivities (Shintani, et al. 2005). 
 
 
 
Figure 2.16. Rh-catalyzed coupling of ortho-carbonylated arylboronic acids and alkynes 
(Source: Shintani, et al. 2005) 
 
It was also reported that the rhodium-catalyzed recation of alkynyl oxiranes 
with arylboronic acids leads to -allenols diastereoselectively(Miura, et al. 2007a)  
(Figure 2.17). 
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Figure 2.17. Rh-catalyzed reaction of phenylboronic acids with alkynyl oxiranes 
(Source: Miura, et al. 2007) 
 
The mechanism explains the stereoselective formation of syn addition product. 
Firstly, a phenylrhodium(I) species is generated by transmetalation. Then, cis 1,2-
addition of the phenylrhodium(I) species to alkynyl oxirane forms the 
alkenylrhodium(I) intermediate. Precoordination of oxygen atom of the oxirane ring 
with rhodium provides high stereoselectivity. -Oxygen elimination takes place to open 
the oxirane ring (Figure 2.18).   
 
 
 
Figure 2.18. Proposed mechanism for the Rh-catalyzed reaction of phenylboronic acids 
with alkynyl oxiranes. (Source: Miura, et al. 2007). 
 
It was found when using an enantiomerically enriched alkynyl oxiranes that the 
reaction proceeded with complete central-to-axial chirality transfer (Miura, et al. 2009). 
In 2002, it was demonstrated that the Rh-catalyzed reaction of phenylboronic 
acid to a chiral proargyl acetate produces an allene (Murakami and Igawa 2002). This 
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study also provided that -AcO elimination of an organorhodium(I) complex took place 
with both syn and anti modes (Figure 2.19). 
 
  
 
 
 
 
 
 
Figure 2.19. Possible mechanism of Rh catalyzed addition and -acetate elimination  
reaction in both anti and syn modes. (Source: Murakami and Igawa 2002) 
 
In this study, an allylic acetate is formed by simple addition to carbon-carbon 
triple bond without changing optical configuration. This result shows that allylic cation 
does not form from intermediate of allylic acetate. Thus, -AcO elimination proceeds 
through E2 type pathway (anti-coplanar conformation is preferred) instead of E1. 
Solvent is very important effect for the configurational selectivity of the process. When 
the reaction is performed in methanol, the (R)-allene is the major enantiomer (31% ee), 
while in ethanol, the (S)-allene formation predominated (17% ee). The reason can be 
resulted from solvent polarity and steric effects.  
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It was reported in 2010 that the asymmetric Rh-catalyzed enantioselective 1,6-
addition of arylboronic acids to enynamides leads to axially chiral allenylsilanes 
(Nishimura, et al. 2010) (Figure 2.20).  
 
 
 
Figure 2.20. Asymmetric Rh catalyzed enantioselective 1,6-addition of arylboronic 
acids to enynamides (Source: Nishimura, et al. 2010). 
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CHAPTER 3 
 
ALLENES 
 
3.1. What is Allene? 
 
Hydrocarbons having a central sp hybridized carbon atom which is connected 
to two other sp2 hybridized carbon atoms is called allene, also known as cumulated 
diene (Figure 3.1).  
 
 
 
Figure 3.1. Cumulated Diene (Allene) 
 
The structure of allenes looks like elongated tetrahedron and they are chiral 
when terminal carbon atoms possess two different substituents. The absolute 
configuration of chiral allenes can be assigned according to the sign (clockwise or 
counterclockwise) of rotation, they can be assigned as R or S (Figure 3.2).  
 
 
 
Figure 3.2. Configurational determination of chiral allene. 
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3.2. Allenes in Use 
 
Allenes are very interesting and useful molecules exhibiting pharmacological 
activities. They also exist as natural products. Thus, the chemistry of allenes becomes 
very popular and attractive area for scientists. The scientists try to isolate and 
characterize new allenic natural products and also they try to discover efficient 
procedure to synthesize enantiomerically pure allene molecules. 
Allenes having functional groups show impressive activities as mechanism-
based enzyme inhibitors, cytotoxic, or antiviral agents. 
Axial chiralty of allenes is very important for their biological activity. For 
example, R-(-)-adenallene has anti-HIV activity whereas S-(+)-adenallene has no anti-
HIV activity (Zemlicka 1997) (Figure 3.3). 
 
OH
H
B
H
HB
H OH
(R) (S)
B:Adenine
 
 
Figure 3.3. Activity of axial chirality 
(Source: Zemlicka 1997) 
 
As a natural product, an insect pheromone (Pheromone of Acanthoscelides 
obtectus) isolated from male dried bean beetles is an interesting allenic product which 
was discovered in 1970 by Horler.  
 
 
 
Figure 3.4. The vinylallene pheromone (Pheromone of Acanthoscelides obtectus) 
isolated from male dried bean beetles (Source: Horler 1970) 
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This pheromone can also be obtained synthetically with the palladium-
catalyzed SN2’-substitution reaction of the bromodiene with dimethyl malonate in the 
presence of cesium tert-butanolate and catalytic amounts of the chiral ligand (R)-
segphos to lead dicarboxylated allene with 77% ee and following decarboxylation and 
selenoxide-mediated dehydrogenation processes (Ogasawara, et al. 2005) (Figure 3.5). 
 
 
 
Figure 3.5. Synthesis of vinylallene insect phreromone 
(Source: Ogasawara, et al. 2005) 
 
3.2. Synthesis of Vinyl Allenes 
 
3.2.1. Synthesis of Vinyl Allenes with Grignard Reagents 
 
Cl
R1
R2
R3
MeMgI
EtOH, reflux
1a : R1=R2=H, R3= Me                                          2a : 50%
1b : R1=Me, R2=R3= H                                         2b : 52%
1c : R1=R2=Me, R3 = H                                         2c : 75%
1d : R1=R2=R3=Me                                               2d : 78%
•
H
R1
Me R2
R3
H
MeMgI Me3SiCl
Mg/HMPA48%
50%Cl
Me
• Me
Me
• TMS
Me
 
 
Figure 3.6. The reaction of chloro-enynes with grignard reagents 
(Source: Gore and Dulcere 1972) 
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It was found that MeMgI or Me3SiMgCl reacted with 2,4-enyne halides to lead 
the E/Z mixture of vinyl allenes (Gore and Dulcere 1972) (Figure 3.6). 
Formation of vinyallene is a limited process with Grignard reagent since use of 
this method is not applicable for other Grignard reagents.  
 
3.2.2. Synthesis of Vinylallenes with Organocopper Reagents 
 
In 1999, it was reported that (E)-2-en-4-yne acetates can effectively undergo 
SN2’’ type alkylation with various lithium cuprates affording an E- and Z- isomeric 
mixture of vinylallenes (Purpura and Krause 1999) (Figure 3.7).  
 
R32CuLi
R1=R2=Me, R3=Bu                                   90% (E:Z = 67:33)                   
R1=R2=Me, R3=t-Bu                                 93% (E:Z = 25:75)
R1=Me3Si, R2=t-Bu, R3=Me                     96% (E:Z = 40:60)
R1=Bu, R2=t-Bu, R3=Me                          92% (E:Z > 99:1)
R1
R2
OAc
•R3
R1
R2
 
 
Figure 3.7. Reactions of enyne acetates with lithium dialkylcuprates 
(Source: Purpura and Krause 1999) 
 
This method can also be applied for the reactions of enyne oxiranes leading 
vinylallenols. When the terminal oxirane was used as a substrate, only E-isomer of 
desired product was formed, however, E and Z isomeric mixture of vinylallenols were 
obtained when alkyl substituted oxirane was used (Figure 3.8). 
 
 
 
Figure 3.8.  Reactions of enyne oxiranes with lithium dialkylcuprates 
(Source: Purpura and Krause 1999) 
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3.2.3. Rhodium-Catalyzed Asymmetric 1,6-Addition of Aryltitanates to 
Enynones Giving Axially Chiral Allenes 
 
It was reported that the addition of aryltitane reagents to 3-alkynyl-2-en-1-ones 
in the presence of chlorotrimethylsilane and rhodium-(R)-segphos as a catalyst led to 
high yields of axially chiral allenylalkenyl silyl enol ethers (Hayashi and Yamasaki 
2003) (Figure 3.9).  
.  
 
 
Figure 3.9. Synthesis of chiral allenylalkenyl silyl enol ethers 
(Source: Hayashi and Yamasaki 2003) 
 
3.2.4. Palladium-Catalyzed Alkoxycarbonylation of (Z)-2-En-4-yne 
Carbonates Leading to 2,3,5-Trienoates 
 
It was recently reported that (Z)-2-en-4-yne carbonates gave carbonylation 
reaction in the presence of a balloon pressure of CO in an alcohol and palladium 
catalyst to lead vinylallenyl esters. According to NMR analyses, E-configured 
vinylallenyl esters were achieved in high yields (Akpinar, et al. 2011) (Figure 4.10).  
 
R1
R2
R3 COOR
4
R2
R3R1
MeO2CO
Pd(0) (1%), PPh3 (2%)
R4OH, CO (balloon pressure)
 
 
Figure 3.10. Pd(0)-catalyzed alkoxycarbonylation of Z-enyne carbonates 
(Source: Akpinar, et al. 2011) 
 
In this study, chirality transfer was also examined and no center-to-axis 
chirality transfer selectivity was shown with this method an enantiomeriallyc enriched 
enyne carbonate (94.5 % ee) led to racemic mixture of desired product. 
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3.2.5. Palladium-Catalyzed 1,5-Substitution Reactions of 2-En-4-yne 
Carbonates with Organoboronic Acids 
 
It was recently published that 2-en-4-yne carbonates gave 1,5-substitution 
reactions with organoboronic acids to lead arylated vinylallenes. The palladium-
catalyzed method, which proceeds through formation of vinylallenylpalladium 
intermediate, is applicable for both (E)- and (Z)- configured enyne carbonates and 
appeared to have wider scope for both organoboronic acids and enyne substrates 
(	

, et al. 2011).   
 
 
 
Figure 3.11. Pd(0)-catalyzed 1,5-substitution reactions of  enyne carbonates 
(Source: 	

, et al. 2011) 
 
No center-to-axis chirality transfer selectivity could be demonstrated with the 
existing method, as in the case for the Pd(0)-catalyzed alkoxycarbonylation applications 
with these substrates (Akpinar, et al. 2011). The relevant reaction of an enantio-enriched 
enyne carbonate (R,Z) (94.5% ee) with phenylboronic acid led to a racemic mixture of 
the product. 
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CHAPTER 4 
 
EXPERIMENTAL STUDY 
 
4.1. General Procedures for Drying the Solvents and Synthesis of 
Catalysts 
 
Tetrahydrofuran (THF), dimethylformamide (DMF), and dichloromethane 
(DCM) solvents were all purified by a solvent purification system (MBRAUN SPS-
800). Et2O was distilled from benzophenone-ketyl under argon prior to use. The 
[RhCl(cod)]2 (Giordano, et al. 2007) and [RhOH(cod)]2 (Uson, et al. 2007)
  complexes 
were synthesized in laboratory.  
 
4.2. Synthesis of Substrates 
 
4.2.1. Synthesis of Z-Enyne Acetates 1b, 1c, 1g, 1h, and E-1a : 
 
 
 
Figure 4.1. Synthesis of Z-Enyne Acetates 1a, 1b, 1f, 1g,  and  E-1a 
 
To the mixture of commercially available, (Z)-pent-2-en-4-yn-1-ol (S1) (1.6 g, 
20 mmol) and 3,4-dihydropyran (2.2 mL) was added p-toluenesulfonic acid (44 mg, 
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0.02 mmol) and then stirred for 45 min at room temperature. Then, the mixture was 
diluted with 40 mL of dry THF under argon and cooled to -78 °C. At that temperature, a 
24 mmol hexane solution of BuLi (1.6 M, 15 mL) was added dropwise via a syringe. 
After stirring the reaction mixture for 1 h at 0 °C, 2.5 mL of alkyl iodide (40 mmol) 
was added dropwise. The mixture was stirred overnight at room temperature when the 
alkyl halide used was MeI, or 2 days at 50 °C when BuI was used. The reaction was 
quenched by the addition of saturated NH4Cl (aq) solution and the reaction solution was 
extracted with Et2O. The organic phase was washed with water, dried over MgSO4, 
filtered, and concentrated under reduced pressure. The residue was used in the 
following step without any other purification. (Betzer, et al. 1997) 
To a solution of the preceding crude compound (S3) in methanol (60 mL) p-
toluenesulfonic acid (1.2 g, 6 mmol) was added and the resulting solution stirred at RT 
for 45-60 min. Then, triethylamine was added (1.8 mL), and the solution was 
concentrated under reduced pressure. The mixture was taken into dichloromethane and 
washed with water. The combined extracts were washed with brine, dried over MgSO4, 
filtered, and concentrated under reduced pressure. Purification by column 
chromatography on silica gel (hexane/ethyl acetate as the eluent) gave the enynol S4 
(yields: R1= Me, 86%; Bu, 80%) (Purpura and Krause 1999).  
To the solution of S4 (17 mmol) in 66 mL of dry diethyl ether, 30 g of 
activated MnO2 was added, and the mixture was stirred overnight at room temperature. 
After filtration through Celite, the solution was concentrated under reduced pressure. 
The crude aldehyde (S5) was used in the next step. (Betzer, et al. 1997). 
The crude aldehyde (S5) was dissolved in 36 mL of anhydrous THF and 
treated at -78 °C with 1.2 equivalent ethereal solution of R3MgX (1.6-2.0 M, X stands 
for iodine in the case of methylation, and bromine for the others) under Ar. At the end 
of the addition of the Grignard reagent, the mixture was warmed with stirring to -40 °C 
at nearly 2 h and then, hydrolyzed by the addition of 30 mL of a saturated NH4Cl 
solution. After extraction with diethyl ether, the combined organic layers were washed 
with water, dried over MgSO4, and filtered. The solvent was removed in vacuo, and the 
crude residue was purified by column chromatography on silica gel (hexane/ethyl 
acetate, yields: R1= Bu, R3= Me, 65%; R1= Me, R3=Bu, 80%; R1= Me, R3= i-Pr, 40%). 
(E)-4-methylhept-3-en-5-yn-2-yl acetate ((E)-1a) was synthesized according to 
a reported method (Purpura and Krause 1999).   
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The preparation of acetates from the synthesized enynols (S6) was performed 
via a prescribed method (Purpura and Krause 1999). The products were purified by 
column chromatography on silica gel (hexane/ethyl acetate) (yields: 1a, 66%; 1b, 70%.; 
1h, 48%; 1i, 50%,  1m 65%). 
 
4.2.2. Synthesis of Z-Enyne Acetates 1c-1e 
 
 
 
Figure 4.2. Synthesis of Z-Enyne Acetates 1c-1e 
 
To a solution of alkynoic ester (S7) (40 mmol) and acetic acid (240 mmol, 
13.8 mL) (512 mmol, 20.8 mL when (S7) is ethyl 3-phenylpropiolate was added sodium 
iodide (9.6 g, 64 mmol) (19.2 g, 128 mmol when (S7) is ethyl 3-phenylpropiolate) and 
stirred for 3 h at 115 °C. After completion of the reaction, the brown mixture was 
transferred while hot to a separatory funnel containing water (10 mL/mmol of the ester 
substrate). The reaction flask was washed with a mixture of water (5 mL) and diethyl 
ether (30 mL/mmol of the ester substrate). The washings were combined in a 
separatory funnel. The phases were separated and the aqueous phase was extracted with 
diethyl ether. The combined organic phases were treated sequentially with saturated 
aqueous sodium bicarbonate, aqueous sodium thiosulfate (1 M), and brine and then 
were dried over MgSO4, filtered, and concentrated under reduced pressure. The product 
was purified by column chromatography on silica gel (hexane/ethyl acetate, yields, 
(S8): R2= H, 84%, Me, 87%; Bu, 84%; Ph, 93%) (Piers, et al. 1994).  
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A mixture of (S8) (35 mmol), PdCl2(PPh3)2 (210.6 mg, 0.3 mmol), and CuI 
(33 mg, 0.17 mmol), in 140 mL of Et3N was stirred for 10 min at room temperature 
under Ar, and then, to this mixture was added a terminal alkyne (38 mmol). The mixture 
was stirred at room temperature for 3h. At the end of the reaction, water was added to 
the resulting mixture and then extracted with Et2O The combined organic layers were 
dried over MgSO4. The solvent was evaporated in vacuo and the product (S9) was 
purified by column chromatography on silica gel (hexane/ethyl acetate, yields: R1= Bu, 
R2= H, 92%; R1= Ph, R2= Me, 93%; R1= c-Hex, R2= Me, 90%; R1= t-Bu, R2= Me, 85%; 
R1= Bu, R2= Bu, 92; R1= Bu, R2= Ph, 82) (Takeuchi, et al. 2000). 
 A dry, three-necked, round-bottomed 250-mL flask equipped with an internal 
thermometer, a rubber septum, and an Ar gas inlet, was charged with 31 mmol of (S9) 
and 63 mL of anhydrous dichloromethane. The stirred solution was cooled to -78 °C 
and 31 mL of a 1 M solution of diisobutylaluminum hydride in hexane was added 
dropwise with a syringe at such a rate that the temperature would not exceed -75 °C. 
After stirring for 30 min at -78 °C, 17 mL Et2O solution of a MeMgI (34 mmol, 2.0 M) 
was added dropwise at -78 °C with a syringe. The cooling bath was removed and the 
reaction mixture was allowed to warm to room temperature. The mixture was 
hydrolyzed at -20 °C by dropwise addition of 63 mL of a 1 M aqueous solution of 
hydrochloric acid, followed by addition of 81 mL of ether. The organic layer was 
separated, the aqueous layer was extracted with ether, and the combined extracts were 
dried over MgSO4. The solvent was evaporated in vacuo. The product was purified by 
column chromatography on silica gel (hexane/ethyl acetate; yields: R1= Bu, R2= H, 
65%; R1= Ph, R2= Me, 55%; R1= c-Hex, R2= Me, 48%; R1= t-Bu, R2= Me, 60%; R1= 
Bu, R2= Bu, 44%; R1= Bu, R2= Ph, 40%) (Marek 1998). 
The preparation of acetates from the synthesized enynols (S6) was performed 
via a prescribed method (Purpura and Krause 1999). The products were purified by 
column chromatography on silica gel (hexane/ethyl acetate).(yields: 1c, 70%; 1d, 64%.; 
1e 65%). 
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4.2.3. Synthesis of non-2-en-4-yn-3ylbenzene 
 
 
 
Figure 4.3. Synthesis of non-2-en-4-yn-3ylbenzene 
 
 To a stirred solution of 1-hexyne (6.5 mL, 59 mmol) in THF (150 mL) were 
added 1.6 M hexane solution of n-BuLi (40.5 mL, 64 mmol) at –78 °C. After stirring 
was continued for 1 h, (4.8 g, 49 mmol) was added  dropwise to the reaction mixture at 
the same temperature, and stirring was continued for 2 h at the same  temperature. The 
reaction mixture was diluted with water and then extracted with AcOEt. The combined 
extracts were washed with brine. The crude product was used for next step (Dieter, et al. 
2005) 
To a stirred solution of alkynylalcohol (9.8 g, 49 mmol) in pyridine (200 mL) 
was added POCl3 (13.8 mL, 148 mmol) at 0 °C, and the stirring was continued for 2 h at 
rt. The reaction mixture was diluted with water at 0 °C and extracted with AcOEt. The 
combined extracts were washed with brine, and the residue upon workup was 
chromatographed on silica gel with only hexane as eluent to give enyne (%55) 
(Yoshida, et al. 2007). 
 
4.2.4 Synthesis of (R,Z)-4-methylhept-3-en-5-yn-2-yl acetate              
[(R,Z)-1a] 
 
Sharpless’s kinetic resolution method was employed for the preparation of 
(R,Z)-4-methylhept-3-en-5-yn-2-ol. Accordingly, 22.9 mmol of Ti(OiPr)4, and 27.5 
mmol of L-(+)-diisopropyl tartrate, were dissolved in 200 mL of dry DCM and cooled 
to -20 °C. To this mixture, dry DCM solution of 22.9 mmol of racemic mixture of (Z)-4-
methylhept-3-en-5-yn-2-ol was added and then stirred for 30 min at -20 °C. Then, 45.8 
mmol of t-butyl hydroperoxide (4 M in toluene) was added and left in a freezer (-20 °C) 
for 13.5 h. After completion, a pre-cooled (0 °C) 37 mL aqueous solution of 42.4 mmol 
FeSO4 and 68.7 mmol tartaric acid mixtures were added to the reaction mixture with 
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small portions while stirring at -20 °C. The mixture was slowly warmed to room 
temperature over 1 h, and then extracted with DCM. The DCM solution was 
concentrated by evaporation and 103 mL of Et2O was added. The ethereal solution was 
cooled to 0 °C, and 109 mL of aqueous NaOH was added and stirred at this temperature 
for 1.5 h. Extraction with ether, drying with MgSO4, and following column 
chromatography on silica gel using hexane/ethyl acetate eluent yielded the isolated 
product at 45% (Verhoeven 1979).  Enantiomeric purity was determined as 94.5% ee by 
GC method using a Hydodex-beta-3P column (25 m, 0.25 mm ID). []D
22= -1.9° (c= 
1.0, CHCl3). Its hydroxyl group was modified to carbonate as described above. []D
22= -
1.2° (c= 0.2, in CHCl3). Specific Rotation was determined according to Equation 4.1. 
 
 
4.3. Characterization of Reactants 
 
The synthesized reactants were analyzed by GC and GC-MS (HP 6890/5973N) 
and isolated by column chromatography using a hexane-ethyl acetate eluent. High-
resolution mass spectral analyses were performed at the Dortmund University of 
Technology Mass Spectrometry Laboratory on a Thermo Electron system. NMR spectra 
were recorded on a Varian VnmrJ 400 spectrometer, a Varian Mercury AS 400, or a 
Bruker DRX 400 spectrometer. Infrared spectra were obtained using a Perkin–Elmer 
Spectrum 100 by ATR method with neat samples. Optical rotations were measured on a 
Rudolph Autopol I polarimeter. 
 
 
 
 
 
 
 
 
(4.1) 
 27 
Me
Me
AcO Me  
 
Figure 4.4. (Z)-4-methylhept-3-en-5-yn-2-yl acetate 
 
1a:  1H NMR (400 MHz, CDCl3)  5.71 (dq, J= 8.8, 6.8 Hz, 1H), 5.56 (dq, J= 
8.8, 1.2 Hz, 1H), 2.01 (s, 3H), 1.97 (s, 3H), 1.81 (d, J= 1.2 Hz, 3H), 1.28 (d, J= 6.8 Hz, 
3H); 13C NMR (101 MHz, CDCl3) : 170.4, 134.9, 121.5, 91.7, 77.7, 70.3, 23.5, 21.5, 
20.5, 4.5; IR (νmax/cm
-1): 2982, 2233, 1730, 1639, 1433, 1235, 1152, 1046; MS (EI, 
m/z): 166 (11, M+), 151 (37), 137 (4), 123 (100), 109 (92), 91 (98), 79 (33); HRMS (EI, 
m/z, M+): 166.0988 (calculated), 166.0993 (found). 
 
Me
AcO MeBu  
 
Figure 4.5. (Z)-4-methyldec-3-en-5-yn-2-yl acetate 
 
1b: 1H NMR (400 MHz, CDCl3) : 5.73 (dq, J= 8.4, 6.4 Hz, 1H), 5.56 (dq, J= 
8.4, 1.4 Hz, 1H), 2.34 (t, J= 7.0 Hz, 2H), 2.02 (s, 3H), 1.83 (d, J= 1.6 Hz, 3H), 1.38-
1.58 (m, 4H), 1.29 (d, J= 6.4 Hz, 3H), 0.92 (t, J= 7.2 Hz, 3H); 13C NMR (101 MHz, 
CDCl3): : 170.3, 134.9, 121.6, 96.4, 78.6, 70.4, 30.9, 23.6, 22.1, 21.5, 20.4, 19.3, 13.7; 
IR (νmax/cm
-1): 2941, 2870, 2223, 1736, 1636, 1371, 1232, 1036; MS (EI, m/z): 208 (8, 
M+), 193 (8), 179 (4), 165 (100), 151 (24), 137 (14), 123 (49), 109 (88), 91 (82), 79 
(47); HRMS (EI, m/z, M+): 208.1458 (calculated), 208.1455 (found). 
 
Me
Me OAc
 
 
Figure 4.6. (Z)-6-cyclohexyl-4-methylhex-3-en-5-yn-2-yl acetate 
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1c: 1H NMR (400 MHz, CDCl3) : 5.78-5.66 (m, 1H), 5.56 (dq, J= 8.4, 0.8 Hz, 
2H), 2.55-2.48 (m, 1H), 2.01 (s, 3H), 1.82 (d, J= 1.2 Hz, 3H), 1.83-1.76 (m, 2H), 1.66-
1.74 (m, 2H), 1.43-1.53 (m, 3H), 1.30-1.37 (m, 3H), 1.35 (d, J= 5.6 Hz, 3H); 13C NMR 
(100 MHz, CDCl3) : 170.3, 134.8, 128.6, 121.8, 100.5, 78.5, 70.3, 63.4, 32.8, 29.8, 
26.0, 24.9, 23.6, 21.5, 20.4; IR (νmax/cm
-1): 2971, 2929, 2854, 2212, 1737, 1448, 1368, 
1234, 1153, 1041; MS (EI, m/z): 234 (10, M+), 219 (12), 191 (89), 177 (19), 149 (26), 
131 (31), 117 (24), 109 (100), 91 (51), 77 (25); HRMS (EI, m/z, M+): 234.1614 
(calculated), 234.1616 (found). 
 
Bu
Bu
AcO Me  
 
Figure 4.7. (Z)-4-butyldec-3-en-5-yn-2-yl acetate 
 
1d: 1H NMR (400 MHz, C6D6) : 6.25 (dq, J= 8.4, 6.4 Hz, 1H), 5.67 (d, J= 8.8 
Hz, 1H), 2.15 (t, J= 6.8 Hz, 2H), 2.11 (t, J= 8.0 Hz, 2H), 1.69 (s, 3H), 1.56 (quint, J= 
7.6 Hz, 2H), 1.42-1.31 (m, 4H), 1.38 (d, J= 6.4 Hz, 3H), 1.30-1.20 (m, 2H), 0.85 (t, J= 
7.2 Hz, 3H), 0.81 (t, J= 7.2 Hz, 3H); 13C NMR (101 MHz, C6D6) : 169.4, 135.1, 126.7, 
97.1, 78.5, 70.1, 37.4, 31.1, 30.8, 22.4, 22.2, 21.0, 20.7, 19.4, 14.1, 13.7; IR (νmax/cm
-1): 
2955, 2932, 2865, 2216, 1742, 1631, 1457, 1369, 1237, 1041; MS (EI, m/z): 250 (3, 
M+) 235 (10), 221 (3), 207 (80), 190 (28), 161 (33), 151 (68), 133 (48), 119 (51), 105 
(100), 91 (98), 77 (34); HRMS (EI, m/z, M+): 250.1927 (calculated), 250.1928 (found). 
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Figure 4.8. (Z)-4-phenyldec-3-en-5-yn-2-yl acetate 
 
1e: 1H NMR (400 MHz, C6D6) : 7.70-7.65 (m, 2H), 7.17-7.04 (m, 3H), 6.42 
(dq, JAB= 8.4, 6.4 Hz, 1H), 6.34 (d, JAB= 8.4 Hz, 1H), 2.18 (t, J= 6.8 Hz, 2H), 1.70 (s, 
3H), 1.44-1.29 (m, 4H), 1.42 (d, J= 6.4 Hz, 3H), 0.81 (t, J= 7.2 Hz, 3H); 13C NMR (101 
MHz, C6D6) : 169.4, 138.2, 135.3, 128.7, 128.4, 126.7, 126.2, 99.2, 77.4, 70.4, 31.0, 
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22.3, 20.9, 20.5, 19.5, 13.7; IR (νmax/cm
-1): 2960, 2932, 2865, 2233, 1739, 1368, 1234, 
1039, 761, 693; MS (EI, m/z): 270 (6, M+) 255 (6), 227 (63), 211 (16), 185 (42), 167 
(100), 153 (94), 141 (33), 128 (34), 115 (37), 91 (23), 77 (14); HRMS (EI, m/z, M+): 
270.1614 (calculated), 270.1613 (found). 
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AcO Bu  
 
Figure 4.9. (Z)-7-methyldec-6-en-8-yn-5-yl acetate 
 
1f: 1H NMR (400 MHz, C6D6) : 6.12 (dt, J= 8.4, 6.8 Hz, 1H), 5.55 (dq, J= 8.6 
Hz, 1.0 Hz, 1H), 1.83-1.74 (m, 2H), 1.76 (d, J= 1.2 Hz, 3H), 1.72 (s, 3H), 1.60 (s, 3H), 
1.38-1.25 (m, 4H), 0.84 (t, J=7.2 Hz, 3H); 13C NMR (101 MHz, C6D6): : 169.4, 134.7, 
122.6, 91.8, 78.6, 73.3, 34.9, 27.6, 23.6, 22.9, 20.9, 14.2, 4.05; IR (νmax/cm
-1): 2958, 
2922, 2857, 2232, 1738, 1634, 1363, 1371, 1234, 1018, 953; MS (EI, m/z): 208 (5, M+), 
193 (14), 165 (59), 151 (43), 123 (28), 109 (100), 91 (49), 79 (32); HRMS (EI, m/z, 
M+): 208.1458 (calculated), 208.1456 (found). 
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Figure 4.10. (Z)-2,5-dimethyloct-4-en-6-yn-3-yl acetate 
 
1g: 1H NMR (400 MHz, C6D6) : 6.01 (dd, J= 8.8, 6.4 Hz, 1H), 5.55 (dq, J= 
8.8, 0.8 Hz, 1H), 1.98 (octet, J= 6.8 Hz, 1H), 1.77 (d, J= 1.6 Hz, 3H), 1.72 (s, 3H), 1.60 
(s, 3H), 0.98 (d, J= 6.8 Hz, 3H), 0.95 (d, J= 6.8 Hz, 3H); 13C NMR (101 MHz, C6D6) : 
169.3, 132.7, 123.6, 91.7, 78.8, 77.4, 33.0, 23.8, 20.8, 18.4, 18.1, 4.10; IR (νmax/cm
-1): 
2963, 2920, 2876, 2240, 1733, 1637, 1435, 1369, 1232, 1017, 972, 606; MS (EI, m/z): 
194 (4, M+), 179 (2), 151 (41), 137 (8), 119 (24), 109 (100), 91 (15), 79 (13); HRMS 
(EI, m/z, M+): 194.1301 (calculated), 194.1307 (found). 
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Figure 4.11. (Z)-4-methyl-6-(trimethylsilyl)hex-3-en-5-yn-2-yl acetate 
 
1h 1H-NMR (400 MHz C6D6)  6.17(dq, J=14.8, 6.4Hz, 1H), 5.58(dd, J=8.2, 
0.7Hz, 1H), 1.68-1.67(m, 6H), 1.27(d, J=6.4Hz, 3H), 0.20(s, 9H) 13C-NMR (100 MHz, 
C6D6): : 169.2, 138.4, 132.5, 121.3, 103.6, 100.5, 69.6, 63.0, 22.8, 20.9, 20.3, 0.04 IR 
(νmax/cm
-1): 3655, 3455, 2981, 2898, 2793, 2147, 1735, 1628, 1369, 1234, 1145, 1045, 
952, 914, 880,839, 759, 700, 634, 610, 508 MS (EI, m/z): 224 (33, M+), 209 (24), 195 
(27), 181 (89), 165 (17), 149 (47), 135 (6), 117 (46), 109 (92), 91 (19), 73 (100) HRMS 
(EI, m/z, [M]+): 224.1227 (calculated), 224.1221 (found). 
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Figure 4.12. (Z)-4-methyl-6-phenylhex-3-en-5-yn-2-yl acetate 
 
1i:  1H-NMR (400 MHz C6D6)  7.53(dt, J=6.0, 1.6Hz, 2H), 6.99-6.93(m, 3H), 
6.28(dt, J=15.4, 6.4Hz, 1H), 5.62(dd, J=8.6, 1.4Hz, 1H), 1.77(d, J=1.6Hz, 3H), 1.69(s, 
3H), 1.30(d, J=6.4Hz, 3H) 13C-NMR (100 MHz, C6D6): : 169.4, 137.2, 132.0, 128.7, 
128.6, 123.6, 121.4, 95.7, 87.8, 69.7, 23.0, 20.9, 20.5 IR (νmax/cm
-1): 3652, 3451, 3060, 
2976, 2464, 2200, 1952, 1734, 1596, 1567, 1490, 1443, 1309, 1235, 1185, 1138, 1042, 
1016, 950, 913, 849, 755, 690, 609 MS (EI, m/z): 228 (9, M+), 213 (25), 185 (100), 171 
(37), 167 (92), 152 (82), 141 (27), 128 (39), 115 (33), 102 (13), 91 (15), 77 (15), 63 (8), 
51 (8) HRMS (EI, m/z, [M]+): 228.11448 (calculated), 228.11355 (found). 
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Figure 4.13. (Z)-4,7,7-trimethyloct-3-en-5-yn-2-yl acetate 
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1j: 1H-NMR (400 MHz C6D6)  6.2(dt, J=14.7, 6.5Hz, 1H), 5.55(dd, J=8.0, 
1.4Hz, 1H), 1.73(d, J=1.6Hz, 3H), 1.69(s, 3H), 1.32(d, J=6.4Hz, 3H), 1.23(s, 9H) 13C-
NMR (100 MHz, C6D6): : 169.3, 135.7, 122.0, 104.6, 77.8, 69.8, 31.0, 28.3 23.4, 20.9, 
20.5 IR (νmax/cm
-1): 3451, 2971, 2870, 2221, 1741, 1630, 1451, 1370, 1306, 1239, 1201, 
1147, 1046, 942, 853 MS (EI, m/z): 208(46% M+), 193 (20), 165 (49), 151 (46), 133 
(60), 123 (24), 109 (100), 105 (56), 95 (11), 91 (57), 81 (12), 77 (27), 65 (13) HRMS 
(EI, m/z, [M]+): 208.14578 (calculated), 208.14506 (found). 
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Figure 4.14. (Z)-dec-3-en-5-yn-2-yl acetate 
 
1k: 1H-NMR (400 MHz C6D6)  6.18(quintet, J=6.8Hz, 1H), 5.68(dd, J=10.8, 
8.0Hz, 1H), 5.47(dd, J=10.8, 0.8Hz, 1H), 2.10(td, J=6.7, 2.0Hz, 2H), 1.60(s, 3H), 1.38-
1.24(m, 4H), 1.30(d, J=6.4Hz, 3H), 0.78(t, J=7.2Hz, 3H) 13C-NMR (100 MHz, C6D6): 
: 169.3, 140.9, 111.7, 97.6, 76.7, 69.2, 31.0, 22.2, 20.8, 20.3, 19.4, 13.7 IR (νmax/cm
-1): 
3451, 3029, 2959, 2933, 2873, 2211, 1737, 1617, 1454, 1425, 1368, 1326, 1296, 1232, 
1154, 1116, 1094, 1039, 1013, 948, 897, 854, 739, 607, 562 MS (EI, m/z): 194 (5, M+), 
179 (9), 165 (5), 151 (100), 137 (21), 123 (22), 109 (67), 95 (92), 91 (95), 81 (33), 77 
(35), 65 (23) HRMS (EI, m/z, [M]+): 194.13013(calculated), 194.13094 (found). 
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Figure 4.15. (Z)-3-methylnon-2-en-4-ynyl acetate 
 
1l: 1H-NMR (400 MHz C6D6)  5.68 (dt, J=7.0, 1.2Hz, 1H), 4.96(d, J=6.8Hz, 
2H), 2.09(t, J=6.8Hz, 2H), 1.74(d, J=1.2Hz, 3H), 1.66(s, 3H), 1.36-1.22(m, 4H), 0.77(t, 
J=7.2Hz, 3H) 13C-NMR (100 MHz, C6D6): : 170.1, 129.7, 124.2, 96.7, 79.1, 63.3.0, 
31.0, 23.6, 20.7, 22.2, 19.3, 13.7 IR (νmax/cm
-1): 3651, 3461, 2950, 2933, 2870, 2216, 
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1740, 1636, 1433, 1377, 1228, 1103, 1024, 962, 890, 813, 605 MS (EI, m/z): 194 (17, 
M+), 179 (9), 165 (8), 151 (68), 135 (10), 123 (16), 110 (44), 95 (100), 91 (71), 81 (41), 
77 (34), 65 (17) HRMS (EI, m/z, [M]+): 194.13013(calculated), 194.12958 (found).  
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Figure 4.16. (E)-4-methylhept-3-en-5-yn-2-yl acetate 
 
(E)-1a: 1H-NMR (400 MHz CDCl3)  5.65(d, J=9.2, 1H), 5.54-5.61(m, 1H), 
2.01(s, 3H), 1.93(s, 3H), 1.85(d, J=0.8 Hz, 3H), 1.27 (d, J=6.4 Hz, 3H) 13C-NMR (100 
MHz, CDCl3): : 170.4, 134.8, 121.8, 84.7, 81.8, 67.5, 21.4, 20.4, 18.2, 4.3 FTIR 
(νmax/cm
-1): 2980, 2918, 2228, 1731, 1638, 1443, 1154, 1040, 1015, 943, 864, 610; MS 
(EI, m/z): 166 (13, M+), 151 (30), 123 (100), 109 (79),  91 (87), 79 (26), 
 
4.4. General Procedure for Arylation Reactions 
 
To an oven-dried flask containing (Z)-2-en-4-yne acetate (0.3 mmol) and 
arylboronic acid (0.9 mmol, 3 equiv) was added CsF (0.45 mmol, 1.5 equiv), 
[RhOH(cod)]2 (6 mol % Rh), degassed water (0.1 mL), and dry THF (2.0 mL), 
successively, under Ar. The reaction mixture was stirred magnetically at room 
temperature for 16 h. The solvent was removed under reduced pressure and the residue 
was purified by column chromatography using hexane-ethyl acetate as eluent to give 
vinyl allene.  
 
4.5. Characterization of Products 
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Figure 4.17. (E)- 2-phenyl-4-methylhepta-2,3,5-triene 
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3aa: 1H NMR (400 MHz, CDCl3) : 7.34-7.38 (m, 2H), 7.28-7.33 (m, 2H), 
7.14-7.21 (m, 1H), 6.06 (dq, J= 15.6, 1.6 Hz, 1H), 5.64 (dq, J= 16.0, 6.8 Hz, 1 H), 2.09 
(s, 3H), 1.90 (s, 3H), 1.80 (dd, J= 6.8, 1.6 Hz, 3H); 13C NMR (100 MHz, CDCl3) : 
207.0, 137.8, 129.2, 128.3, 126.4, 125.8, 124.5, 101.8, 99.6, 18.3, 17.1, 15.5; FTIR 
(νmax/cm
-1): 3029, 2981, 2911, 1933, 1598, 1491, 1444, 1367, 1065, 1026, 961, 757, 
690, 603, 594; MS (EI, m/z): 184 (100, M+), 169 (98), 154 (86), 141 (70), 128 (51), 115 
(36), 105 (19), 91 (30), 77 (15); HRMS (ESI, m/z, (M+H)+): 185.1325 (calculated), 
185.1324 (found). 
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Figure 4.18. ((E)-2-(4-(trifluoromethyl)-phenyl)-4-methylhepta-2,3,5-triene 
 
3ab: 1H NMR (400 MHz, CDCl3) : 7.54 (d, JAB= 8.0 Hz, 2H), 7.44 (d, JAB= 
8.0 Hz, 2H), 6.05 (dq, J= 16.0, 2.0 Hz, 1H), 5.64 (dq, J=15.6, 6.8 Hz, 1H), 2.1 (s, 3H), 
1.91 (s, 3H), 1.79 (dd, J= 6.8, 1.6 Hz, 3H); 13C NMR (100 MHz, CDCl3) : 207.8, 
141.7, 128.5, 128.3 (q, J=32 Hz) 125.9, 125.4, 125.1 (q, J= 3.9 Hz), 124.4 (q, J= 270 
Hz) 102.5, 99.0, 18.3, 17.0, 15.3; FTIR (νmax/cm
-1): 2987, 2928, 2855, 1933, 1616, 
1323, 1164, 1114, 1074, 1014, 840, 607; MS (EI, m/z): 252 (100, M+), 237 (82), 222 
(21), 209 (43), 197 (64), 183 (26), 168 (36), 153 (39), 141 (17), 128 (14), 115 (13), 91 
(16); HRMS (EI, m/z, M+): 252.1120 (calculated), 252.1119 (found). 
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Figure 4.19. (E)-2-(4-acetylphenyl)-4-methylhepta-2,3,5-triene 
 
3ac: 1H NMR (400 MHz, CDCl3) : 7.89 (d, J= 8.4 Hz, 2H), 7.43 (d, JAB= 8.0  
Hz, 2H), 6.04 (dq, JAB= 15.6, 1.6 Hz, 1H), 5.68 (dq, J= 15.2, 6.8 Hz, 1H), 2.57 (s, 3H), 
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2.1 (s, 3H), 1.9 (s, 3H), 1.80 (dd, J= 6.4, 1.2 Hz, 3H); 13C NMR (100 MHz, CDCl3) : 
208.3, 197.7, 143.0, 135.0, 128.43, 128.39, 125.8, 125.4, 102.4, 99.4, 26.6, 18.4, 17.0, 
15.3; FTIR (νmax/cm
-1): 2925, 2850, 1930, 1681, 1601, 1357, 1266, 959, 838, 646, 602; 
MS (EI, m/z): 226 (100, M+), 211 (57), 183 (37), 168 (43), 153 (39), 141 (24), 128 (19), 
115 (21), 91 (11); HRMS (ESI, m/z, (M+H)+): 227.1430 (calculated), 227.1429 (found). 
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Figure 4.20. (E)-2-(4-meyhylphenyl)-4-methylhepta-2,3,5-triene 
 
3ad: 1H NMR (400 MHz, CDCl3) : 7.24 (d, JAB= 8.0, 2H), 7.11 (d, JAB= 8.0 
Hz, 2H), 6.06 (dq, J= 16.0, 2.0 Hz, 1H), 5.64 (dq, J= 15.6, 6.4 Hz, 1H), 2.32 (s, 3H), 
2.07 (s, 3H), 1.80 (s, 3H), 1.79 (dd, J= 6.8, 1.6 Hz, 3H); 13C NMR (100 MHz, CDCl3) 
: 206.7, 136.1, 134.8, 129.5, 129.0, 125.7, 124.3, 101.7, 99.5, 21.1, 18.3, 17.2, 15.5; 
FTIR (νmax/cm
-1): 3038; 2982, 2921, 2850, 1510, 1444, 1370, 1025, 963, 816, 590; MS 
(EI, m/z): 198 (100, M+), 183 (93), 168 (82), 153 (48), 141 (36), 128 (33), 115 (35), 105 
(18), 91 (30), 77 (19); HRMS (ESI, m/z, (M+H)+): 199.1481 (calculated), 199.1481 
(found). 
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Figure 4.21. (E)-2-(3-meyhylphenyl)-4-methylhepta-2,3,5-triene 
 
3ae: 1H NMR (400 MHz, CDCl3) : 7.20-7.41 (m, 3H), 7.02-7.05 (m, 1H), 
6.10 (dq, J= 15.2, 1.6 Hz, 1H), 5.67 (dq, J= 15.2, 6.4 Hz, 1H), 2.37 (s, 3H), 2.11 (s, 3H), 
1.93 (s, 3H), 1.83 (dd, J= 6.8, 1.6 Hz, 3 H); 13C NMR (100 MHz, CDCl3) : 207.0, 
138.79, 137.8, 129.4, 128.2, 127.3, 126.6, 124.3, 123.0, 101.6, 99.6, 21.6, 18.3, 17.3, 
15.5; FTIR (νmax/cm
-1): 3013, 2918, 2855, 1933, 1604, 1488, 1444, 1376, 1028, 962, 
781, 696; MS (EI, m/z): 198 (100, M+), 183 (87), 168 (78), 153 (47), 141 (37), 128 (32), 
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115 (34), 105 (17), 91 (32); HRMS (ESI, m/z, (M+H)+): 199.1481 (calculated), 
199.1481 (found). 
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Figure 4.22. (E)-2-(3-chlorophenyl)-4-methylhepta-2,3,5-triene 
 
3af: 1H NMR (400 MHz, CD3Cl) : 7.31-7.32 (m, 1H), 7.21-7.23 (m, 2H), 
7.13-7.17 (m, 1H), 6.04 (dq, J= 15.6, 1.6 Hz, 1H), 5.67 (dq, J= 6.8, 15.6 Hz, 1H), 2.07 
(s, 3H), 1.89 (s, 3H), 1.81 (dd, J= 6.8, 1.6 Hz, 3H); 13C NMR (100 MHz, CDCl3) : 
207.3, 140.1, 134.4, 129.5, 128.9, 126.5, 126.0, 125.3, 124.1, 102.5, 99.0, 18.5, 17.3, 
15.6; FTIR (νmax/cm
-1): 3034, 2982, 2916, 2855, 1933, 1592, 1566, 1475, 1443, 1417, 
1368, 1106, 1080, 1067, 1027, 961, 776, 748, 687, 609; MS (EI, m/z): 218 (97, M+), 
203 (70), 183 (33), 175 (19), 168 (100), 153 (77), 141 (45), 128 (31), 115 (33), 102 
(12), 91 (21), 77 (20); HRMS (ESI, m/z, (M+H)+): 219.0935 (calculated), 219.0936 
(found). 
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Figure 4.23. (E)-2-(2-methoxyhenyl)-4-methylhepta-2,3,5-triene 
 
3ag: 1H NMR (400 MHz, CDCl3) : 7.20-7.41 (m, 2H), 6.84–6.93 (m, 2H), 
6.10 (dq, J= 15.6, 1.6 Hz, 1H), 5.54 (dq, J= 16.0, 6.8 Hz, 1H), 3.81 (s, 3H), 2.07 (s, 3H), 
1.84 (s, 3H), 1.78 (dd, J= 6.4, 1.6 Hz, 3H, 13C NMR (100 MHz, CDCl3) : 207.5, 157.0, 
130.1, 129.2, 128.1, 127.9, 123.4, 120.5, 111.4, 98.5, 97.2, 55.7, 19.6, 18.3, 15.7; FTIR 
(νmax/cm
-1): 2924, 1596, 1578, 1491, 1434, 1245, 1029, 962, 749, 603; MS (EI, m/z): 
214 (23, M+), 199 (100), 184 (38), 165 (34), 152 (25), 141 (25), 135 (78), 128 (29), 115 
(34), 91 (30), 77 (28); HRMS (ESI, m/z, (M+H)+): 215.1430 (calculated), 215.1430 
(found). 
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Figure 4.24. (E)- 2-(2-naphthyl)-4-methylhepta-2,3,5-triene 
 
3ah: 1H NMR (500 MHz, CDCl3) : 7.78-7.87 (m, 2H), 7.70-7.77 (m, 2H), 
7.54-7.59 (m, 1H), 7.40-7.52 (m, 2H), 6.14 (dq, J= 16.0, 1.0 Hz, 1H), 5.72 (dq, J= 15.5, 
6.5 Hz, 1H), 2.25 (s, 3H), 1.97 (s, 3H), 1.85 (d, J= 5.5 Hz, 3H); 13C NMR (126 MHz, 
CDCl3) : 208.0, 135.4, 133.8, 132.5, 129.3, 128.1, 127.71, 127.68, 126.2, 125.6, 125.5, 
124.8, 123.5, 102.2, 100.1, 18.5, 17.4, 15.7; FTIR (νmax/cm
-1): 3053, 2982, 2915, 1929, 
1629, 1597, 1505, 1371, 1025, 961, 854, 817, 783, 745; MS (EI, m/z): 234 (100, M+), 
219 (88), 204 (81), 189 (27), 178 (43), 165 (25), 152 (20), 141 (15); HRMS (ESI, m/z, 
(M+H)+): 235.1481 (calculated), 235.1481 (found). 
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Figure 4.25. (E)- 2-(3-thienyl)-4-methylhepta-2,3,5-triene 
 
3ai: 1H NMR (400 MHz, CDCl3) : 7.20-7.23 (m, 1H), 7.01-7.05 (m, 2H), 6.27 
(dq, J= 15.6, 1.6 Hz, 1H), 5.96 (dq, J= 15.6, 6.4 Hz, 1H), 2.06 (s, 3H), 1.87 (s, 3H), 1.79 
(dd, J= 6.8, 1.2 Hz, 3H); 13C NMR (100 MHz, CDCl3) : 206.8, 140.1, 129.3, 126.9, 
125.2, 124.5, 118.7, 103.3, 99.1, 18.3, 17.7, 15.6; FTIR (νmax/cm
-1): 3103, 2987, 2922, 
2855, 1929, 1442, 1368, 1247, 1183, 1026, 962, 864, 775, 644; MS (EI, m/z): 190 (95, 
M+), 175 (100), 160 (45), 147 (32), 142 (59), 134 (23), 129 (17), 115 (25); HRMS (ESI, 
m/z, (M+H)+): 191.0889 (calculated), 191.0889 (found). 
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Figure 4.26. (E)- 6-phenyl-4-methyldeca-2,4,5-triene 
 
3ba: 1H NMR (400 MHz, CDCl3) : 7.37-7.41 (m, 2H), 7.28-7.34 (m, 2 H), 
7.17-7.23 (m, 1H), 6.10 (dq, J= 15.6, 1.6 Hz, 1H), 5.67 (dq, J= 15.6, 6.6 Hz, 1H), 2.47 
(t, J= 7.6, 2H), 1.93 (s, 3H), 1.83 (dd, J= 6.6, 2.0 Hz, 3H), 1.53 (quint, J= 7.2 Hz, 2H), 
1.44 (sext, J= 7.6 Hz, 2H), 0.95 (t, J=7.4 Hz, 3H); 13C NMR (100 MHz, CDCl3) : 
207.0, 137.8, 129.6, 128.4, 126.5, 126.3, 124.4, 105.1, 103.2, 30.3, 30.2, 22.6, 18.5, 
15.7, 14.1; FTIR (νmax/cm
-1): 3025, 2957, 2928, 2859, 1931, 1599, 1492, 1446, 1376, 
961, 757, 693; MS (EI, m/z): 226 (13, M+), 211 (7), 197 (13), 184 (50), 169 (100), 155 
(37), 141 (31), 128 (23), 115 (21), 91 (25), 77 (8); HRMS (EI, m/z, M+): 226.1716 
(calculated), 226.1712 (found). 
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Figure 4.27. (E) 1-cyclohexyl-1-phenyl-3-methyl-hexa-1,2,4-triene 
 
3ca: 1H NMR (400 MHz, C6D6) : 7.44-7.57 (m, 2H), 7.17-7.21 (m, 2H), 7.02-
7.09 (m, 1H), 6.19 (dq, J= 15.6, 1.6 Hz, 1H), 5.54 (dq, J= 15.6, 6.8 Hz, 1H), 2.44-2.52 
(m, 1H), 1.95-2.03 (m, 2H), 1.87 (s, 3H), 1.65 (dd, J= 6.8, 1.6 Hz, 3H), 1.59-1.73 (m, 
3H), 1.24-1.32 (m, 4H), 1.11-1.19 (m, 1H); 13C NMR (101 MHz, C6D6) : 207.1, 137.8, 
130.2, 128.7, 127.2, 126.8, 124.2, 112.2, 104.3, 38.6, 33.3, 33.5, 27.0, 26.8, 18.4, 15.9; 
FTIR (νmax/cm
-1): 3021, 2924, 2851, 1928, 1598, 1493, 1446, 961, 764, 693; MS (EI, 
m/z): 252 (18, M+), 237 (18), 223 (31), 195 (26), 183 (100), 169 (50), 155 (48), 141 
(30), 128 (29), 115 (25), 91 (36), 77 (12); HRMS (EI, m/z, M+): 252.1873 (calculated), 
252.1871 (found). 
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Figure 4.28. (E)-5-phenyl-7-(prop-1-enyl)undeca-5,6-diene 
 
3da: 1H NMR (400 MHz, C6D6) : 7.46-7.53 (m, 2H), 7.16-7.23 (m, 2H), 7.03-
7.09 (m, 1H), 6.14 (dd, J= 15.7, 1.6 Hz, 1H), 5.65 (dq, J= 15.7, 6.7 Hz, 1H), 2.46 (t, J= 
8.0 Hz, 2H), 2.26 (t, J= 7.6 Hz, 2H), 1.66 (dd, J= 6.8, 1.5 Hz, 3H), 1.54-1.64 (m, 4H), 
1.30-1.41 (m, 4H), 0.88 (t, J= 7.2 Hz, 3H), 0.85 (t, J= 7.2 Hz, 3H); 13C NMR (101 
MHz, C6D6) : 206.8, 138.0, 129.4, 128.7, 126.9, 126.5, 124.1, 108.7, 107.3, 30.8, 
30.61, 30.60, 29.6, 23.2, 23.0, 18.6, 14.3, 14.2; FTIR (νmax/cm
-1): 3023, 2956, 2927, 
2858, 1597, 1493, 1448, 1377, 961, 757, 692; MS (EI, m/z): 268 (2, M+), 239 (4), 226 
(3), 211 (39), 183 (33), 169 (100), 155 (38), 141 (48), 128 (14), 115 (17), 91 (28), 77 
(8); HRMS (EI, m/z, M+): 242.1485 (calculated), 242.1485 (found). 
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Figure 4.29. (E)-4,6-diphenyl-deca-2,4,5-triene 
 
3ea: 1H NMR (400 MHz, C6D6) : 7.50-7.57 (m, 4H), 7.12-7.20 (m, 4H), 7.02-
7.09 (m, 2H), 6.27 (dq, J= 15.6, 2.0 Hz, 1H), 5.96 (dq, J= 15.6, 6.8 Hz, 1H), 2.47 (dt, J= 
7.6, 1H), 2.46 (t, J=7.6 Hz, 1H), 1.62 (dd, J= 6.8, 1.6 Hz, 3H), 1.54-1.65 (m, 2H), 1.31 
(sext, J= 15.6, 2H), 0.82 (t, J= 15.6 Hz, 3H); 13C NMR (101 MHz, C6D6) : 207.7, 
137.3, 137.1, 128.9, 128.8, 128.7, 127.9, 127.4, 127.2, 127.0, 126.5, 111.3, 109.1, 30.6, 
30.5, 23.0, 18.5, 14.2; FTIR (νmax/cm
-1): 3026, 2956, 2929, 2858, 1597, 1492, 1445, 
960, 756, 692; MS (EI, m/z): 288 (8, M+), 259 (19), 246 (168), 231 (100), 215 (77), 202 
(28), 165 (16), 155 (20), 128 (21), 115 (28), 91 (26), 77 (13); HRMS (EI, m/z, M+): 
288.1873 (calculated), 288.1876 (found). 
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Figure 4.30. (E)-4-methyl-2-phenyl-deca-2,3,5-triene 
 
3fa: 1H NMR (400 MHz, CD3Cl) : 7.37-7.43 (m, 2H), 7.31-7.36 (m, 2H), 
7.21-7.24 (m, 1H), 6.08 (dt, J= 19.6, 1.6 Hz, 1H), 5.66 (dt, J= 15.6, 7.2 Hz, 1H), 2.13-
2.20 (m, 2H), 2.13 (s, 3H), 1.93 (s, 3H), 1.32-1.48 (m, 4H), 0.94 (t, J= 7.6 Hz, 3H); 13C 
NMR (101 MHz, CD3Cl) : 207.2, 137.8, 130.08, 128.3, 127.9, 126.4, 125.9, 101.9, 
99.6, 32.7, 31.8, 22.3, 17.1, 15.5, 14.0; FTIR (νmax/cm
-1): 3027, 2956, 2925, 2863, 1933, 
1492, 1444, 1367, 1027, 963, 758, 692, 604, 596; MS (EI, m/z): 226 (38, M+), 211 (21), 
197 (9), 183 (100), 168 (52), 155 (83), 141 (55), 128 (40), 115 (37), 105 (28), 91 (33), 
77 (21); HRMS (ESI, m/z, (M+H)+): 227.1794 (calculated), 227.1795 (found). 
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Figure 4.31. (E)-4,7-dimethyl-2-phenyl-octa-2,3,5-triene 
 
3ga: 1H NMR (400 MHz, C6D6) : 7.32-7.50 (m, 2H), 7.10-7.20 (m, 2H), 7.00-
7.08 (m, 1H), 6.20 (dd, J= 15.8, 1.4 Hz, 1H), 5.59 (dd, J= 15.6, 7.0 Hz, 1H), 2.21-2.32 
(m, 1H), 2.03 (s, 3H), 1.89 (s, 3H), 0.956 (d, J=7.2 Hz, 3H), 0.953 (d, J=7.2 Hz, 3H); 
13C NMR (101 MHz, C6D6) : 207.9, 138.2, 137.0, 128.7, 126.9, 126.4, 125.9, 102.3, 
100.4, 31.9, 22.7, 17.3, 15.7 ppm; FTIR (νmax/cm
-1): 3027, 2958, 2867, 1933, 1597, 
1492, 1465, 1444, 1366, 1066, 1029, 964, 758, 692, 603; MS (EI, m/z): 212 (47, M+), 
197 (100), 182 (32), 169 (31), 165 (29), 155 (48), 141 (36), 128 (35), 115 (29), 91 (24), 
77 (15); HRMS (EI, m/z, M+): 212.1560 (calculated), 212.1551 (found). 
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4.6. Computational Details  
 
The geometry optimizations were performed by using the density functional 
theory (DFT) with Becke Three Parameter Lee, Yang, and Parr, (B3LYP) functional 
and LANL2DZ basis set implemented in Gaussian 09 software (Becke 1993). The 
imaginary frequencies have been checked with the frequencies for these structures. The 
geometry analysis is shown in Supplementary Information for some selected 
geometrical parameters. The natural Bond Orbital (NBO) and Mulliken charges were 
used for the charge analysis. 
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CHAPTER 5 
 
RESULTS AND DISCUSSION 
 
The reaction of a (Z)-configured enyne acetate 1a with 3 equivalents of 
phenylboronic acid proceeded in THF solvent, at room temperature, and in the presence 
of [RhCl(cod)]2 (6% Rh), 3 equivalents of KOH, and 0.1 mL of water to yield the 
desired phenyl-substituted vinylallene 3aa product, which, however, was accompanied 
by significant amounts of nonseparable intricate isomers of the vinylallene with 
unassigned structures (Table 5.1, entry 1). 
Yet, the reaction halted after a period of time and the conversion was 
incomplete even with the load of higher proportions of Rh at the beginning of the 
reaction, indicating that a change in the composition of reaction medium (possibly due 
to an increased concentration of the acetate dispelled from the enyne substrate) lowered 
the activity of the rhodium significantly. 
The complete conversion of 1a could be attained by substituting the base with 
CsF (entry 2) in the presence of [RhOH(cod)]2 complex. The formation of isomeric 
byproducts could be minimized and thereby high yields of 3aa product could be 
achieved by decreasing the CsF addition to 1.5 equivalent amounts (entries 2-5). The 
fine adjustment of the amount of added water seemed highly critical for the 
effectiveness of the process; the arylative substitution reaction did not proceed to 
completion when the reaction medium contained less or higher than 0.1 mL of water 
(entries 6-8). KF salt could not be an alternative flouride source (entry 9) and the use of 
other Cs compounds instead were useless (entries 10 and 11).  A number of bases, such 
as NEt3, NaOAc, K2CO3, NaOH, K3PO4, NaHCO3, was also tested. However, the 
reactions resulted in incomplete conversion of the Z-enyne 1a and accompanied by the 
formation of byproducts when using any of these bases. 
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Table 5.1. Effect of Base and Water Additives on the Rh(I)-Catalyzed Reaction of Z-
Enyne Acetate 1a with Phenylboronic Acid. 
 
 
entry base (equiv) water (mL) conversion (%)a yield, 3ba (%)a 
1b KOH (3) 0.1 78 58 
2 CsF (3) 0.1 100 55 
3 CsF (2) 0.1 100 75 
4 CsF (1.5) 0.1 100 85 
5 CsF (1.1) 0.1 95 75 
6 CsF (1.5) - 25 20 
7 CsF (1.5) 0.05 77 67 
8 CsF (1.5) 0.2 55 42 
9 KF (3) 0.1 40 38 
10 CsOH (1.5) 0.1 100 50 
11 Cs2CO3 (1.5) 0.1 82 40 
             a Determined by 1H NMR using benzaldehyde as internal standard. 
               
 b Rhodium complex charged was [RhCl(cod)]2. 
 
Having established the effective conditions, an array of substituted boronic 
acids was then subjected to the reactions with the enyne acetate 1a (Table 5.2). The 
reaction tolerated both electron-withdrawing and -donating groups on the m- and p-
positions, giving rise to high yields of the corresponding arylated vinylallene products 
3aa–3af (entries 1-6). A sterically congested organoboronic acid, 2-naphthylboronic 
acid, and 3-thienylboronic acid, were also suitable components for the reaction, yielding 
related products 3ag–3ai with isolated yields in the range of 76–83% (entries 7–9). No 
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successful results could be obtained by the use of 1-naphthyl-, 3-pyridyl-, and 1-
pentenylboronic acids.  
 
Table 5.2. Rh(I)-Catalyzed Reaction of the Z-Enyne Acetate 1a with Organoboronic 
Acids 
 
 
 
entry Ar product isolated yield (%) 
1 2a Ph 3aa 82 
2 2b 4-CF3C6H4 3ab 76 
3 2c 4-MeCOC6H4 3ac 77 
4 2d 4-MeC6H4 3ad 83 
5 2e 3-MeC6H4 3ae 86 
6 2f 3-ClC6H4 3af 77 
7 2g 2-MeOC6H4 3ag 83 
8 2h 2-naphthyl 3ah 76 
9 2i 3-thienyl 3ai 81 
 
The scope of the arylation method was also surveyed for a range of acetates of 
secondary Z-enynols. The method appeared suitable for the enyne acetates bearing butyl 
(1b) or cyclohexyl (1c) groups on the alkynyl moiety (R1, Table 5.3, entries 1 and 2), 
butyl (1d) or phenyl (1e) groups in the R2 position (entries 3 and 4), and butyl (1f) or 
isopropyl (1g) groups on the allylic carbon (R3, entries 5 and 6), affording the 
corresponding vinylallenes in good yields when reacted with phenylboronic acid (70-
79%). The reactions of enynes with substituents; tert-butyl (1j), SiMe3 (1h), or Ph (1i), 
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substituents on the R1 position (R2= R3= Me) and that acetate (1l) of a primary enyne 
alcohol (R1= R2= Me, R3= H) were highly sluggish and afforded the related vinylallene 
products in very low yields, usually <20% (entries 7,8,9 and 10).  
 
Table 5.3. Rh(I)-Catalyzed Reaction of Z-Enyne Acetates with Phenylboronic Acid 
 
 
entry substrate R1 R2 R3 product isolated yield (%) 
1 1b Bu Me Me 3ba 72 
2 1c Cy Me Me 3ca 70 
3 1d Bu Bu Me 3da 75 
4 1e Bu Ph Me 3ea 73 
5 1f Me Me Bu 3fa 79 
6 1g Me Me i-Pr 3ga 77 
7 1h SiMe3 Me Me - <20 
8 1i Ph Me Me - <20 
9 1j tert-Bu Me Me - <20 
10 1k Bu Me H - <20 
 
The Rh(I)-catalyzed reaction of the acetate of an enantiomerically enriched 
enynol reagent, (R,Z)-1a (94.5% ee) with phenylboronic acid under the optimal 
conditions proceeded with partial racemization, and yielded (S)-(+)-vinylallene as the 
major enantiomer (82% isolated yield, 40% ee, []D
25= +0.33 (c= 0.29, CHCl3)) (Figure 
5.2). (Lowe 1965; Ogasawara, et al. 2006; Ogasawara, et al. 2007) 
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The reaction should involve the regioselective cis-1,2-addition of the in-situ 
generated phenylrhodium(I) species across the carbon-carbon triple bond, which should 
be directed through the dual coordinative interaction of rhodium with alkynyl and 
acetate moieties (I), to afford the alkenylrhodium(I) intermediate (II) (Figure 5.2). It 
should be noted that the application of the rhodium-mediated protocol on the following 
conjugated enynes (4 and 5) which lack a leaving group at the allylic carbon resulted in 
complex mixtures of various isomers of mono- and dialkylated products: 
 
Et
Me
Bu
Ph
Me
4 5 
 
Figure 5.1. Conjugated enynes without leaving group 
 
The subsequent -elimination of [Rh]-OAc and double bond migration may 
take place concurrently via both anti- and syn-modes,  syn-deacetylation being the 
major path, to produce the enantiomers of arylated vinylallene products and 
regenerating the active Rh(I) catalyst for the next cycle. Alternatively, the formation of 
a benzylidene--allyrhodium intermediate (III) may precede the deacetylation step. 
 
 
 
Figure 5.2. Stereochemistry of Rh(I)-Catalyzed Arylation of (R,Z)-2-En-4-Yne Acetate. 
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However, in both instances, the elimination step should be activated via the 
coordination of the rhodium and the oxygen functionality (Miura, et al. 2010). Indeed, 
we found that the Rh-mediated protocol is not applicable to E-configured enyne 
acetates; an analogous reaction with (E)-1a furnished a dienyl acetate structure (6) as 
the major product (62% NMR yield) and consequently formation of the desired 
vinylallene product was less than 10% (Figure 5.3). This result indicates that the 
alkenylrhodium intermediate II’ which is arised through rhodoarylation of (E)-1a could 
not undergo the -elimination of [Rh]-OAc, instead, however, underwent demetallation 
to yield a hydroarylated product 6 and that could be ascribed to the fact that the 
intermediate II’ can not maintain a suitable geometry for an effective Rh(I)-OAc 
interaction which seems necessary for the elimination step. 
 

 
Figure 5.3. Rh(I)-Catalyzed Arylation of (E)- 4-methylhept-3-en-5-yn-2-yl acetate 
 
For better rationalization of the observed enantiospecific outcome of the 
rhodium-mediated reaction of (R,Z)-1.1a with phenylboronic acid, we performed 
conformational analyses by using the density functional theory (dft) calculations for the 
intermediate II. The conformations were searched by different combination of rotations 
about four different single carbon-carbon bonds (Q1-Q4), as depicted in Figure 5.4., and 
81 conformers were obtained. Then, more rotations were performed so as to achieve 
conformers which include the rhodium and the acetate group in a sufficient vicinity for 
effective coordination (typically 2.2706-2.2862 Å), which is necessary for the next Rh-
OAc elimination step to form 3. 
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Figure 5.4. The structure of intermediate II which was subjected to dft calculations 
(hydrogens atoms are omitted for clarity) 
 
As a result, the overall conformational analysis study yielded a minimum 
energy that is associated with the conformer ES as shown in Figure 5.5.. Interestingly 
this conformer could potentially follow a [Rh]-OAc elimination path leading to the 
product (S)-3aa. The other structures which are assigned as ER, ZS, and ZR (Figure 
6.5.) represent the conformers of local minimum energies and potentially lead to the 
products (E,R), (Z,S), and (Z,R)-3aa, respectively. The fact that the conformer ER had a 
potential energy that is 3.83 kcal/mol higher than that of the conformer ES may account 
for the resulting enantiomeric ratio of the 3aa products. The relative energies of the ZR 
and ZS as compared to ES are about 6.94 and 8.85 kcal/mol higher, respectively. It 
should be noted that no Z-configured vinylallene production was observed in the course 
of this study. 
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Figure 5.5.  Optimized conformers for the intermediate II (hydrogen atoms are omitted 
for clarity and the energy values are relative energies) 
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CHAPTER 6 
 
CONCLUSION 
 
As a consequence, in this study new method was developed for the synthesis of 
E-configured vinyl allenes with an aryl moiety via the reaction of Z-2,4-enyne acetate 
with arylboronic acids in the presence of a Rh catalyst. [RhOH(cod)]2 was found as the 
most effective complex in catalyzing the reaction. 
Rh(I)-catalyzed reactions proceeded via typically SN2’’ type substitution of 
(Z)-2-en-4-yne acetates, which is triggered by cis-addition of in-situ formed 
nucleophilic arylrhodium(I) species with coordinating of alkynyl and acetate moieties. 
Deacetylation took place in both syn- and anti-modes; nevertheless, syn-elimination was 
the dominating route. The geometry of the (E)-2-en-4-yne acetate wouldn’t allow the 
coordinative interaction of arylrhodium(I) species with both triple bond and oxygen of 
acetate moiety to produce vinylallene. Interestingly, E-enyne acetate underwent 4,5-
arylative nucleophilic addition reaction with the same conditions as Z-enyne acetae to 
produce dienyl acetate product. 
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APPENDIX A 
 
1H NMR AND 13CNMR SPECTRUMS OF REACTANTS 
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Figure A.1. 1 H NMR of (Z)-4-methylhept-3-en-5-yn-2-yl acetate 
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Figure A.2. 13C NMR of (Z)-4-methylhept-3-en-5-yn-2-yl acetate 
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Figure A.3. 1H NMR of (Z)-4-methyldec-3-en-5-yn-2-yl acetate 
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Figure A.4. 13C NMR of (Z)-4-methyldec-3-en-5-yn-2-yl acetate 
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Figure A.5. 1H NMR of (Z)-6-cyclohexyl-4-methylhex-3-en-5-yn-2-yl acetate 
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Figure A.6. 13C NMR of (Z)-6-cyclohexyl-4-methylhex-3-en-5-yn-2-yl acetate 
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Figure A.7. 1H NMR of (Z)-4-butyldec-3-en-5-yn-2-yl acetate 
 
63 
    
 
   
B
u
B
u
A
cO
M
e
1d
Figure A.8. 13C NMR of (Z)-4-butyldec-3-en-5-yn-2-yl acetate 
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Figure A.9. 1H NMR of (Z)-4-phenyldec-3-en-5-yn-2-yl acetate 
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Figure A.10. 1H NMR of (Z)-4-phenyldec-3-en-5-yn-2-yl acetate 
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Figure A.11. 1H NMR of (Z)-7-methyldec-6-en-8-yn-5-yl acetate 
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Figure A.12. 13C NMR of (Z)-7-methyldec-6-en-8-yn-5-yl acetate 
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Figure A.13. 1H NMR of (Z)-2,5-dimethyloct-4-en-6-yn-3-yl acetate 
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Figure A.14. 13C NMR of (Z)-2,5-dimethyloct-4-en-6-yn-3-yl acetate 
 
70 
    
 
   
M
e
3 Si
M
e
A
cO
M
e
1h
Figure A.15. 1H NMR of (Z)-4-methyl-6-(trimethylsilyl)hex-3-en-5-yn-2-yl acetate 
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Figure A.16. 13C NMR of (Z)-4-methyl-6-(trimethylsilyl)hex-3-en-5-yn-2-yl acetate 
 
72 
    
 
   
Ph
M
e
A
cO
M
e
1i
Figure A.17. 1H NMR of (Z)-4-methyl-6-phenylhex-3-en-5-yn-2-yl acetate 
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Figure A.18. 13C NMR of (Z)-4-methyl-6-phenylhex-3-en-5-yn-2-yl acetate 
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Figure A.19. 1H NMR of (Z)-4,7,7-trimethyloct-3-en-5-yn-2-yl acetate 
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Figure A.20. 13C NMR of (Z)-4,7,7-trimethyloct-3-en-5-yn-2-yl acetate 
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Figure A.21. 1H NMR of (Z)-dec-3-en-5-yn-2-yl acetate 
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Figure A.22. 13C NMR of (Z)-dec-3-en-5-yn-2-yl acetate 
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Figure A.23. 1H NMR of (Z)-3-methylnon-2-en-4-ynyl acetate 
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Figure A.24. 13C NMR of (Z)-3-methylnon-2-en-4-ynyl acetate 
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Figure A.25. 1H NMR of (E)-4-methylhept-3-en-5-yn-2-yl acetate 
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Figure A.26. 13C NMR of (E)-4-methylhept-3-en-5-yn-2-yl acetate 
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Figure B.1. Mass Spectrum of (Z)-4-methylhept-3-en-5-yn-2-yl acetate 
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Figure B.2. Mass Spectrum of (Z)-4-methyldec-3-en-5-yn-2-yl acetate 
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Figure B.3. Mass Spectrum of (Z)-6-cyclohexyl-4-methylhex-3-en-5-yn-2-yl acetate Figure B.3. Mass Spectrum of (Z)-6-cyclohexyl-4-methylhex-3-en-5-yn-2-yl acetate 
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Figure B.4. Mass Spectrum of (Z)-4-butyldec-3-en-5-yn-2-yl acetate 
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Figure B.5. Mass Spectrum of (Z)-4-phenyldec-3-en-5-yn-2-yl acetate 
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Figure B.6. Mass Spectrum of (Z)-7-methyldec-6-en-8-yn-5-yl acetate 
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Figure B.7. Mass Spectrum of (Z)-2,5-dimethyloct-4-en-6-yn-3-yl acetate 
Figure B.7. Mass Spectrum of (Z)-2,5-dimethyloct-4-en-6-yn-3-yl acetate 
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Figure B.8. Mass Spectrum of (Z)-4-methyl-6-(trimethylsilyl)hex-3-en-5-yn-2-yl acetate 
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Figure B.9. Mass Spectrum of (Z)-4-methyl-6-phenylhex-3-en-5-yn-2-yl acetate 
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Figure B.10. Mass Spectrum of (Z)-4,7,7-trimethyloct-3-en-5-yn-2-yl acetate 
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Figure B.11. Mass Spectrum of (Z)-dec-3-en-5-yn-2-yl acetate 
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Figure B.12. Mass Spectrum of (Z)-3-methylnon-2-en-4-ynyl acetate 
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Figure B.13. Mass Spectrum of (E)-4-methylhept-3-en-5-yn-2-yl acetate 
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Figure C.1. FTIR Spectrum of (Z)-4-methylhept-3-en-5-yn-2-yl acetate 
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Figure C.2. FTIR Spectrum of (Z)-4-methyldec-3-en-5-yn-2-yl acetate 
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Figure C.3. FTIR Spectrum of (Z)-6-cyclohexyl-4-methylhex-3-en-5-yn-2-yl acetate Figure C.3. FTIR Spectrum of (Z)-6-cyclohexyl-4-methylhex-3-en-5-yn-2-yl acetate 
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Figure C.4. FTIR Spectrum of (Z)-4-butyldec-3-en-5-yn-2-yl acetate 
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Figure C.5. FTIR Spectrum of (Z)-4-phenyldec-3-en-5-yn-2-yl acetate 
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Figure C.6. Mass Spectrum of (Z)-7-methyldec-6-en-8-yn-5-yl acetate 
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Figure C.7. FTIR Spectrum of (Z)-2,5-dimethyloct-4-en-6-yn-3-yl acetate Figure C.7. Mass Spectrum of (Z)-2,5-dimethyloct-4-en-6-yn-3-yl acetate 
 
 
104 
  
 
   
M
e
3 Si
M
e
A
cO
M
e
1h
Figure B.8. Mass Spectrum of (Z)-4-methyl-6-(trimethylsilyl)hex-3-en-5-yn-2-yl acetate 
Figure C.8. Mass Spectrum of (Z)-4-methyl-6-(trimethylsilyl)hex-3-en-5-yn-2-yl acetate 
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Figure C.9. FTIR Spectrum of (Z)-4-methyl-6-phenylhex-3-en-5-yn-2-yl acetate 
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Figure B.10. FTIR Spectrum of (Z)-4,7,7-trimethyloct-3-en-5-yn-2-yl acetate Figure C.10. FTIR Spectrum of (Z)-4,7,7-trimethyloct-3-en-5-yn-2-yl acetate 
 
 
 
107 
   
 
  
B
u
H
A
cO
M
e
1k
Figure C.11. FTIR Spectrum of (Z)-dec-3-en-5-yn-2-yl acetate 
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Figure C.12. FTIR Spectrum of (Z)-3-methylnon-2-en-4-ynyl acetate 
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Figure B.13. Mass Spectrum of (E)-4-methylhept-3-en-5-yn-2-yl acetate 
Figure C.13. FTIR Spectrum of  (E)-4-methylhept-3-en-5-yn-2-yl acetate 
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Figure D.1. 1 H NMR of (E)- 2-phenyl-4-methylhepta-2,3,5-triene 
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Figure D.2. 13 C NMR of (E)- 2-phenyl-4-methylhepta-2,3,5-triene 
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Figure D.3. 1 H NMR of ((E)-2-(4-(trifluoromethyl)-phenyl)-4-methylhepta-2,3,5-triene 
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Figure D.4. 13 C NMR of ((E)-2-(4-(trifluoromethyl)-phenyl)-4-methylhepta-2,3,5-triene 
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Figure D.5. 1 H NMR of (E)-2-(4-acetylphenyl)-4-methylhepta-2,3,5-triene 
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Figure D.6. 13 C NMR of (E)-2-(4-acetylphenyl)-4-methylhepta-2,3,5-triene 
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Figure D.7. 1 H NMR of (E)-2-(4-meyhylphenyl)-4-methylhepta-2,3,5-triene 
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Figure D.8. 13 C NMR of (E)-2-(4-meyhylphenyl)-4-methylhepta-2,3,5-triene 
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Figure D.9. 1 H NMR of (E)-2-(3-meyhylphenyl)-4-methylhepta-2,3,5-triene 
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Figure D.10. 13 C NMR of (E)-2-(3-meyhylphenyl)-4-methylhepta-2,3,5-triene 
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Figure D.11. 1 H NMR of (E)-2-(3-chlorophenyl)-4-methylhepta-2,3,5-triene 
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Figure D.12. 13 C NMR of (E)-2-(3-chlorophenyl)-4-methylhepta-2,3,5-triene 
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Figure D.13. 1 H NMR of (E)-2-(2-methoxyhenyl)-4-methylhepta-2,3,5-triene 
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Figure D.14. 13 C NMR of (E)-2-(2-methoxyhenyl)-4-methylhepta-2,3,5-triene 
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Figure D.15. 1 H NMR of ((E)- 2-(2-naphthyl)-4-methylhepta-2,3,5-triene 
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Figure D.16. 13 C NMR of ((E)- 2-(2-naphthyl)-4-methylhepta-2,3,5-triene 
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Figure D.17. 1 H NMR of (E)- 2-(3-thienyl)-4-methylhepta-2,3,5-triene 
 
 
128 
      
 
   
Figure D.18. 13 C NMR of (E)- 2-(3-thienyl)-4-methylhepta-2,3,5-triene 
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Figure D.19. 1 H NMR of (E)- 6-phenyl-4-methyldeca-2,4,5-triene 
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Figure D.20. 13 C NMR of (E)- 6-phenyl-4-methyldeca-2,4,5-triene 
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Figure D.21. 1 H NMR of (E)-1-cyclohexyl-1-phenyl-3-methyl-hexa-1,2,4-triene 
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Figure D.22. 13 C NMR of (E)-1-cyclohexyl-1-phenyl-3-methyl-hexa-1,2,4-triene 
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Figure D.23. 1 H NMR of (E)-5-phenyl-7-(prop-1-enyl)undeca-5,6-diene 
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Figure D.24. 1 H NMR of (E)-5-phenyl-7-(prop-1-enyl)undeca-5,6-diene 
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Figure D.25. 1 H NMR of (E)-4,6-diphenyl-deca-2,4,5-triene 
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Figure D.26. 13 C NMR of (E)-4,6-diphenyl-deca-2,4,5-triene 
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Figure D.27. 1 H NMR of (E)-4-methyl-2-phenyl-deca-2,3,5-triene 
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Figure D.28. 13 C NMR of (E)-4-methyl-2-phenyl-deca-2,3,5-triene 
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Figure D.29. 1 H NMR of (E)-4,7-dimethyl-2-phenyl-octa-2,3,5-triene 
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Figure D.30. 13 C NMR of (E)-4,7-dimethyl-2-phenyl-octa-2,3,5-triene 
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Figure E.1. Mass Spectrum of (E)- 2-phenyl-4-methylhepta-2,3,5-triene 
 
143 
     
 
     
Figure E.2. Mass Spectrum of ((E)-2-(4-(trifluoromethyl)-phenyl)-4-methylhepta-2,3,5-triene 
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Figure E.3. Mass Spectrum of (E)-2-(4-acetylphenyl)-4-methylhepta-2,3,5-triene 
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Figure E.4. Mass Spectrum of (E)-2-(4-meyhylphenyl)-4-methylhepta-2,3,5-triene 
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Figure E.5. Mass Spectrum of (E)-2-(3-meyhylphenyl)-4-methylhepta-2,3,5-triene 
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Figure E.6. Mass Spectrum of (E)-2-(3-chlorophenyl)-4-methylhepta-2,3,5-triene 
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Figure E.7. Mass Spectrum of (E)-2-(2-methoxyhenyl)-4-methylhepta-2,3,5-triene 
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Figure E.8. Mass Spectrum of ((E)- 2-(2-naphthyl)-4-methylhepta-2,3,5-triene 
 
 
150 
     
 
     
Figure E.9. 1 H NMR of (E)- 2-(3-thienyl)-4-methylhepta-2,3,5-triene 
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Figure E.10. Mass Spectrum of (E)- 6-phenyl-4-methyldeca-2,4,5-triene 
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Figure E.11. Mass Spectrum of (E)-1-cyclohexyl-1-phenyl-3-methyl-hexa-1,2,4-triene 
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Figure E.12. Mass Specttrum of (E)-5-phenyl-7-(prop-1-enyl)undeca-5,6-diene 
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Figure E.13. Mass Spectrum NMR of (E)-4,6-diphenyl-deca-2,4,5-triene 
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Figure E.14. Mass Spectrum (E)-4-methyl-2-phenyl-deca-2,3,5-triene 
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Figure E.15. Mass Spectrum of (E)-4,7-dimethyl-2-phenyl-octa-2,3,5-triene 
 
 157 
APPENDIX F 
 
FTIR SPECTRUMS OF PRODUCTS 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
158 
    
4000 .0 3600 3200 2800 2400 2000 1800 1600 1400 1200 1000 800 550.0
30 .0
35
40
45
50
55
60
65
70
75
80
85
90
95
100
105
110
115.0
cm-1
%T 
2983.10
2910.91
2726.80
2378.22
1932.50
1870.44
1799.20
1748.17
1597.80
1577.93
1491.02
1466.08
1443.70
1367.11
1303.63
1271.02
1232.44
1182.49
1156.28
1099.30
1065.48
1025.68
960.80
920.77
907.38
792.70
757.38
691.71
619.04
602.99
594.08
3081.79
3034.30
2860.15
2944.59
 
    
Figure F.1. FTIR Spectrum of (E)- 2-phenyl-4-methylhepta-2,3,5-triene 
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Figure E.2. FTIR Spectrum of ((E)-2-(4-(trifluoromethyl)-phenyl)-4-methylhepta-2,3,5-triene 
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Figure F.3. FTIR Spectrum of (E)-2-(4-acetylphenyl)-4-methylhepta-2,3,5-triene 
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Figure F.4. FTIR Spectrum  of (E)-2-(4-acetylphenyl)-4-methylhepta-2,3,5-triene 
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Figure F.5. FTIR Spectrum of (E)-2-(3-meyhylphenyl)-4-methylhepta-2,3,5-triene 
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Figure F.6. FTIR Spectrum of (E)-2-(3-chlorophenyl)-4-methylhepta-2,3,5-triene 
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Figure F.7. FTIR Spectrum of (E)-2-(2-methoxyhenyl)-4-methylhepta-2,3,5-triene 
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Figure F.8. FTIR Spectrum of ((E)- 2-(2-naphthyl)-4-methylhepta-2,3,5-triene 
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Figure F.9. FTIR Spectrum of (E)- 2-(3-thienyl)-4-methylhepta-2,3,5-triene 
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Figure F.10. FTIR Spectrum of (E)- 6-phenyl-4-methyldeca-2,4,5-triene 
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Figure F.11. FTIR Spectrum of (E)-1-cyclohexyl-1-phenyl-3-methyl-hexa-1,2,4-triene 
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Figure F.12. FTIR Spectrum of (E)-5-phenyl-7-(prop-1-enyl)undeca-5,6-diene 
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Figure F.13. FTIR Spectrum of (E)-4,6-diphenyl-deca-2,4,5-triene 
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Figure F.14. FTIR Spectrum of (E)-4-methyl-2-phenyl-deca-2,3,5-triene 
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Figure F.15. FTIR Spectrum of (E)-4,7-dimethyl-2-phenyl-octa-2,3,5-triene 
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APPENDIX G 
  
 HPLC CHROMATOGRAMS OF REACTANT AND  
PRODUCTS 
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Figure G.1. HPLC Spectrum of (R,Z)-4-methylhept-3-en-5-yn-2-yl acetate 
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Figure G.2. HPLC Spectrum for racemic mixture of  (E)- 2-phenyl-4-methylhepta-2,3,5-triene 
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Figure G.3. HPLC Spectrum for racemic mixture of  (E)- 2-phenyl-4-methylhepta-2,3,5-triene 
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Figure G.4. HPLC Spectrum for racemic mixture of  (E)- 2-phenyl-4-methylhepta-2,3,5-triene 
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Figure G.4. HPLC Spectrum for racemic mixture of  (E)- 2-phenyl-4-methylhepta-2,3,5-triene 
 
•
Ph
M
e
M
e
M
e
+
•
Ph
M
e
M
e
M
e
(S)-3aa (R)-3aa
[RhCl(R,R-Bn-bod)]2, RT : 37% ee
 179 
 
 
APPENDIX H 
 
 GC CHROMATOGRAMS OF RACEMIC AND 
ENANTIOMERICALLY PURE (Z)-4-METHYLHEPT-3-EN-
5-YN-2-OL 
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Figure H.1. GC Spectrum of Racemic 4-methylhept-3-en-5-yn-2-ol  
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Figure H.2. GC Spectrum of Enantiomerically Pure 4-methylhept-3-en-5-yn-2-ol  
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 COMPUTATIONAL CALCULATIONS DATA  
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Figure I.1. The structure of the intermediate II which was subjected to conformational 
analysis by DFT calculation 
 
 
Table I.1. Some Selected Geometrical Parameters for the Optimized Conformers of the 
Intermediate IIa 
 
 ES ER ZS ZR 
Rh58-C2 2.0608 2.0769 2.0656 2.0710 
Rh58-C38 2.1381 2.1358 2.1362 2.1386 
Rh58-C40 2.1480 2.1401 2.1507 2.1584 
Rh58-C39 2.3124 2.3166 2.2961 2.3154 
Rh58-C41 2.2708 2.2596 2.2699 2.2630 
Rh58-C3 4.5488 4.5130 4.5431 4.5519 
Rh58-C21 3.6354 4.1694 3.8739 3.6509 
Rh58-C27 5.4462 4.7614 3.9633 4.2148 
Rh58-C34 4.5146 4.5238 4.3586 4.5249 
Rh58-O33 2.2862 2.2521 2.2399 2.2706 
Rh58-O31 4.1065 3.7225 3.8532 4.1887 
O33-C32 1.2568 1.2610 1.2581 1.2547 
O33-C27 4.2443 4.0630 3.0171 3.1583 
O33-C38 4.3106 4.3193 4.2240 4.3285 
O33-C40 4.3959 4.3328 4.3776 4.3684 
O33-C39 3.1974 3.3631 3.2584 3.2098 
O33-C41 3.1456 3.1999 3.2958 3.0810 
C32-O31 1.3517 1.3492 1.3498 1.3497 
C25-O31 1.5397 1.5364 1.5114 1.5535 
C1-C2 1.3691 1.3727 1.3724 1.3687 
C2-C18 1.4910 1.4962 1.4962 1.4887 
C18-C19 1.3678 1.3651 1.3625 1.3693 
C3-C21 3.6901 3.2297 3.3743 3.6018 
C3-C27 4.4296 6.1353 5.8712 3.7638 
 184 
C3-C34 7.2882 4.8906 4.7043 7.4435 
C21-C27 4.9153 4.9737 4.8474 4.7275 
C21-C34 6.2662 6.3260 6.2940 6.1987 
C27-C34 4.7401 4.6623 4.4240 4.4924 
C27-C7 5.5588 6.8677 6.3048 4.1578 
O31-C32-O33 124.5 124.4 124.8 125.3 
C2-Rh58-C38 93.5 92.8 94.5 91.7 
C7-C1-C18-C21 -114.9 112.3 -108.9 114.7 
C3-C1-C7-C8 -32.4 -135.9 152.4 -144.1 
C1-C2-C18-C19 -86.8 123.4 -105.4 93.5 
C7-C1-C2-Rh58 -3.9 -10.3 5.8 7.6 
C8-C7-C2-Rh58 130.6 27.3 -18.3 33.7 
H20-C19-C25-H26* -173.3 -124.2 -41.8 29.5 
a Distances are given in angstrom, angles in degrees.  
 
Table I.2. The Natural Bond Orbital (NBO) Charge Analysis for the Optimized 
Conformers of the Intermediate II 
 
  ES ER ZS ZR 
1 C -0.07284 -0.05770 -0.07039 -0.06755 
2 C -0.17116 -0.19526 -0.17233 -0.17630 
3 C -0.65531 -0.66407 -0.66213 -0.65852 
4 H 0.22071 0.22450 0.22576 0.22210 
5 H 0.22087 0.21383 0.22283 0.21670 
6 H 0.21554 0.22568 0.21401 0.22078 
7 C -0.04490 -0.03468 -0.04207 -0.04447 
8 C -0.21720 -0.20932 -0.21009 -0.20225 
9 C -0.20097 -0.21630 -0.21882 -0.21680 
10 C -0.21330 -0.21458 -0.21667 -0.21484 
11 H 0.21216 0.22296 0.21724 0.21840 
12 C -0.21681 -0.21296 -0.21193 -0.21344 
13 H 0.22262 0.21224 0.21299 0.21234 
14 C -0.22832 -0.22865 -0.22909 -0.22880 
15 H 0.21455 0.21335 0.21377 0.21379 
16 H 0.21459 0.21468 0.21465 0.21469 
17 H 0.21427 0.21422 0.21426 0.21429 
18 C 0.02100 0.03214 -0.00154 0.02735 
19 C -0.30188 -0.29285 -0.29094 -0.31114 
20 H 0.20771 0.20693 0.21277 0.20828 
21 C -0.63389 -0.63353 -0.61976 -0.63162 
22 H 0.22606 0.22277 0.22398 0.22404 
23 H 0.22627 0.22332 0.21553 0.22517 
24 H 0.21628 0.21439 0.21218 0.21610 
25 C 0.11453 0.12656 0.12278 0.11883 
 185 
26 H 0.23011 0.21497 0.23351 0.23077 
27 C -0.63984 -0.64338 -0.64778 -0.65757 
28 H 0.21967 0.22565 0.22995 0.23727 
29 H 0.22685 0.22521 0.22192 0.22309 
30 H 0.23103 0.22810 0.23014 0.23527 
31 O -0.58922 -0.57925 -0.57864 -0.59308 
32 C 0.89372 0.90212 0.90805 0.89272 
33 O -0.62956 -0.62822 -0.62898 -0.63029 
34 C -0.71117 -0.70636 -0.70584 -0.70960 
35 H 0.24739 0.25802 0.24565 0.24595 
36 H 0.24307 0.24551 0.26371 0.24017 
37 H 0.24609 0.24440 0.24378 0.24739 
38 C -0.19146 -0.20057 -0.20047 -0.20771 
39 C -0.23192 -0.23596 -0.23003 -0.23572 
40 C -0.22493 -0.21507 -0.21744 -0.20590 
41 C -0.22846 -0.21991 -0.23036 -0.22292 
42 C -0.42944 -0.42877 -0.42816 -0.43070 
43 C -0.43400 -0.43475 -0.43327 -0.43429 
44 H 0.22859 0.24103 0.21899 0.24211 
45 H 0.22759 0.23654 0.22969 0.23666 
46 H 0.22482 0.22972 0.22499 0.23179 
47 H 0.21015 0.20735 0.20895 0.20818 
48 H 0.22390 0.22338 0.22336 0.22363 
49 H 0.22066 0.22720 0.22120 0.22345 
50 C -0.43223 -0.43010 -0.43154 -0.43072 
51 C -0.43294 -0.43150 -0.43255 -0.43192 
52 H 0.23468 0.22951 0.23475 0.22807 
53 H 0.24315 0.22643 0.24417 0.23212 
54 H 0.22946 0.21968 0.22748 0.21827 
55 H 0.22380 0.22275 0.22319 0.22392 
56 H 0.22749 0.22621 0.22711 0.22653 
57 H 0.20839 0.21044 0.20923 0.21055 
58 Rh 0.14399 0.10195 0.11825 0.14537 
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Table I.3 HOMO-LUMO energies of intermediates 
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Figure I.2 HOMO-LUMO figures of intermediates 
 
 
Table I.4 HOMO-LUMO energies of products 
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Figure I.3 HOMO-LUMO figures of products 
 
